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Protein kinase R (PKR) is a key component of the interferon-induced immune
response to viral stress. It contains two N-terminal dsRNA binding domains (dsRBD)
and a C-terminal serine/threonine kinase domain separated by a 90 residue
unstructured linker of unknown function.

PKR is activated by viral dsRNAs via

dimerization and autophosphorylation of specific serine and threonine residues. We
have developed an assay to measure dimerization of PKR while bound to various
dsRNAs using Fӧrster resonance energy transfer. This is the first direct measurement of
PKR dimerization upon dsRNAs binding. Our results show that inactive dimers of PKR
exist in solution, and that a specific back-to-back dimer configuration is essential for
activation. The role of the interdomain linker was determined by characterizing linkerdeleted constructs of PKR. We propose that the unstructured linker may exist to
negatively regulate PKR activation by limiting it’s binding stoichiometry and curbing
dsRNA-independent activation. The role of the second dsRNA binding domain was
probed by mutating residues likely to contact dsRNA. Collectively, the studies presented
here provide new insight on the elusive mechanism of dsRNA induced PKR activation.
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1.1 Role of PKR in immune response and signaling
Protein kinase R is a critical component of the innate immune response to a variety of
stress stimuli such as viral infection1. It exists endogenously in host cells in a latent
inactive state and is over-expressed upon induction by type I interferon2. PKR contains
tandem N-terminal dsRNA binding domains separated by a 20-residue linker and a Cterminal kinase domain. The kinase and dsRNA binding domains are separated by a
long unstructured linker of ~90 residues in length. PKR recognizes and binds to viral
RNAs that are generated in the cell as a by-product of viral replication3,4, and becomes
activated via dimerization and autophosphorylation5. Activated PKR phosphorylates
eIF2α, which impairs the initiation of translation of host and viral proteins in the cell6.
eIF2A is a heterotrimeric complex comprising of α, β and γ subunits. In the GTP bound
form and in the presence of eIF2B it is able to bind to the initiating Met-tRNA and can
transfer the tRNA to the 40S ribosome to initiate protein translation via GTP-GDP
exchange7. Phosphorylation of eIF2α at S51 locks the subunit in a GDP-bound state
incapable of binding to the Met-tRNA and initiating protein translation. Consequently the
translational machinery is unable to synthesize viral and host proteins eventually
leading to apoptosis, thus containing the spread of the infection. In addition to the eIF2α
phosphorylation, PKR participates in a myriad of cellular signaling pathways, which
relate to cell proliferation, tumor suppression, and activation of transcription factors such
as interferon8. In the absence of stimulus the transcription factor NFκB is sequestered in
the cytosol by two inhibitory proteins IκBα and IκBβ in the cytosol9. The binding of these
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proteins block the nuclear localization sequence as well as the DNA binding region of
NFκB thus inhibiting its ability to serve as a transcriptional regulator. Phosphorylation
the of the IκB proteins at specific serine and threonine positions lead to the dissociation
from NFκB and they are then tagged for proteasomal degradation via polyubiquitnation.
IκB phosphorylation is mediated by IKK (IκB kinases), which is a substrate of active
PKR. Phosphorylated PKR activates IKK and mediates the release of NFκB, which can
transcriptionally regulate various genes involved in immunity, inflammation, cell
proliferation and differentiation among many10.
1.2. Mechanism of PKR activation by dsRNA
PKR binds to dsRNA in a sequence non-specific manner and binds most strongly to
perfect duplexes3. The dsRNA binding domains of PKR are members of a large family
of homologous domains, including Xlrbpa2 from Xenopus laevis. The crystal structure of
Xlrbpa2 in complex with 16 bp duplex show that the intermolecular interactions are
primarily between positively charged residues on the dsRBD and backbone
phosphodiester oxygen and 2’-OH groups on the dsRNA. Xlrbpa2, which is a single
dsRBD, makes contacts within two minor grooves and the adjoining major groove and
has a footprint of 16 bp11.

PKR contains two such dsRBDs. PKR is activated by

dsRNAs in a length dependent manner. The shortest dsRNA that can activate PKR is
30 bp12,13. Activation follows a “bell-shaped” pattern as a function of dsRNA
concentration due to the inhibition of PKR activation at high dsRNA concentrations14,15.
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Mechanism of PKR activation by variable length duplex RNAs

Fig. 1.1. Domain organization of PKR.

PKR is a member of the host anti-viral interferon induced defense pathway and is
activated upon binding to viral dsRNA containing complex secondary structural
features16. PKR consists of a C-terminal kinase domain and an N-terminal dsRBD
separated by a 90 residue unstructured linker (Figure 1.1.). The N terminal lobe of the
kinase is involved in forming the dimer interface and the C terminal lobe contains the
substrate recognition site for eIF2α17. The nucleotide-binding site is located in between
the two lobes. The dsRBD consists of tandem dsRNA binding motifs (dsRBM) 1 and 2,
each having the conserved αβββα fold separated by a short linker18. The structures of
the kinase domain17 and dsRBD18 have been solved by X-ray crystallography and NMR,
respectively. No structure of full length PKR is available.
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Fig. 1.2. Dimerization model for PKR activation by dsRNAs ≥ 30 bp.

PKR is biased to binding A-form dsRNA19. Studies performed previously have revealed
that the 30 bp duplex is the minimum length dsRNA that can activate PKR (Figure 2). It
is also the minimum length required for the binding of two PKR monomers13. These
results led to the proposal of the dimerization model for PKR activation by duplex RNAs
in which the role of the dsRNA is to bind two PKR monomers, leading to dimerization
and activation.
The effect of salt concentration on the stoichiometry and binding affinity of PKR to
dsRNA has been studied previously13. It was observed that a decrease in the NaCl
concentration from 200 mM to 75 mM leads to a considerable increase in binding affinity
as determined by sedimentation velocity and fluorescence anisotropy experiments.
Constructs of the dsRBM1 alone and the dsRBD have been studied for their
interaction with variable length duplex RNAs20. The stoichiometry with which the
dsRBM1 binds dsRNA increases sequentially with RNA length as a result of the
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increase in number of available configurations. However, the dsRBD consisting of both
motifs does not display the same trend.

The stoichiometry of binding increases

systematically from 15-35 bp, and then decreases with dsRNAs longer than 35 bp. This
indicates a greater site size on longer activating duplexes relative to shorter nonactivating sequences. 1H-15N HSQC NMR spectra of the dsRBD have been examined
upon titration with 20 bp and 40 bp dsRNAs. The resonances most affected upon 20 bp
interactions correspond to regions in the dsRBM1 and the N-terminus of the dsRBM2.
However upon 40 bp titration residues corresponding to both the dsRNA binding motifs
showed significant chemical shifts, indicating that the dsRBM2 makes additional
interactions with longer, activating dsRNAs.
1.3. RNAs that interact with PKR in vivo
Several viral and cellular RNAs have been found to activate PKR. The internal ribosome
entry site (IRES) RNA produced by the Hepatitis C virus consists of several domains
with complex secondary structural elements such as internal loops, bulges and a
pseudoknot21,22. At least one of the domains has been found to activate PKR through a
partial structural mimicry of A-form dsRNA. The 3’-UTR of tumor necrosis factor – α
(TNF- α) mRNA has also been found to activate PKR indicating that cellular regulation
of PKR also occurs23. Several viruses have developed mechanisms to block the
activation of PKR and its downstream signaling processes. Adenovirus and Epstein Barr
virus (EBV) produce inhibitory RNAs that abrogate PKR dimerization and activation24,25.
Adenovirus VAI consists of three domains: an apical stem, a central domain and a
terminal stem. VAI as well as the mutant of VAI lacking the terminal stem inhibit PKR
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activation to the same extent. Interestingly it was shown that the apical stem and central
domains of PKR together form a site for the binding of a single PKR molecule26,27.
One of the most well studied dsRNAs that interact with PKR is the human
immunodeficiency virus type - 1 transactivation-responsive region (TAR) RNA28-30. It is
a 23 bp stem loop RNA with three bulges that is known to dimerize. The TAR dimer
consists of a 46 bp duplex region with an internal loop. Monomeric TAR is an inhibitor of
PKR, whereas the TAR dimer is known to activate PKR (Figure 3). Sedimentation
velocity studies reveal that the TAR dimer is capable of binding two monomers of PKR
thereby allowing PKR dimerization and activation. This is also indicative of PKR’s ability
to accommodate internal loops or barriers to dimerization.
	
  

Fig. 1.3.Mechanism of activation of PKR by TAR RNA dimer.

1.4.Correlation between dimerization and autophosphorylation
The mechanism for dsRNA-induced PKR activation involves the formation a specific
back-to-back dimer interface that was observed in the crystal structures of the kinase
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domains bound to eIF2α17. PKR dimerizes weakly in the solution and can be activated
in the absence of dsRNA31. Activation results in the autophosphorylation of specific
serine and threonine residues within the kinase32,33. T446 in the activation segment is
critical for the active enzyme and K296 is essential for phosphotransfer near the ATP
binding site.

The kinase domain of PKR (258-551) has a canonical bilobal

architecture. The N-lobe comprises of a five-stranded antiparallel β sheet and two
helices α0 and αC. The residues that form the dimer interface reside exclusively within
the N-lobe, many of which are in the helix αC. The C-lobe is larger containing eight α
helices and two β strands. The N-terminal region of the helix αG in the C-lobe as well as
residues within the activation segment make specific contacts with PKR’s substrate
eIF2α. The ATP binding site exists in the cleft between the two lobes. K296-E308 ion
pair in the active site aid in coordinating the nucleotide moiety and for phosphotranfer.
K296R mutants are catalytically inactive but are still able to bind nucleotides. Threonine
446 within the activation segment of the kinase domain dimers are phosphorylated in
the structure. K304 and R307 side chains protruding from the helix αC and R416 from
the C lobe coordinate phosphorylated T446. Therefore, the specific configuration of
helix αC may be critical for facilitating the formation of the active enzyme. Mutational
analysis of residues within the dimer interface perturbed and in some cases abolished
PKR activation. The dimer interface is held together by a number of residues specifically
a salt bridge R262-D266 and a hydrogen bonding interaction between Y323-D289Y293. In addition I288 interacts with hydrophobic interaction with a large buried surface
area contributing significantly to dimer interface. The back-to-back dimer involves
several residues within the helix αC. In addition, the other end of the helix αC contains
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residues that co-ordinate the T446 within the active cleft. Therefore, there exists an
allosteric link between the formation of the dimer interface and the activation of PKR.
PKR is capable of dimerization in the absence of dsRNA and the Kd for self-associated
was measured previously to be 500 µM31. Upon phosphorylation the affinity for
dimerization increased by 1000 fold to ~ 500 nM.
	
  
N lobe
a)

b)
K296

αC

αC
E308

K304
R307

AMP-PNP

pT446

C lobe

	
  

Figure 1.4. Allosteric linkage between dimerization and activation a) Back-to-back dimer of
kinase b) Active site of kinase with AMP-PNP
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1.5. Unstructured regions within PKR
	
  

	
  
Figure 1.5. Inter-domain linkers of PKR.

Four of fifteen phosphorylation sites exist within the N-terminal region including
threonine and serine residues in the linker region. One of the sites (S33) is located
within dsRBD1 and may make contacts with dsRNA when bound. When PKR is
autophosphorylated it has an enhanced affinity for dimerization and a reduced affinity
for dsRNA. Therefore even a small amount of dsRNA can be recycled to initiate the
activation of several PKR molecules. It is suggested that phosphorylation at S33
reduces the affinity for dsRNA and therefore is a critical site in the context of the
autocatalytic cascade. The kinase domain is separated from the N-terminal region by a
long unstructured linker. The linker contains only one phosphorylation site (S242) and
alanine substitution at this site causes a slight attenuation of PKR activation potency but
does not block activation33. The linker can be divided into two sections based on
sequence homology and amino acid content. The region 169-229 is abundant in polar
uncharged residues, which is a signature of disordered proteins. It is also interspersed
with negatively charged residues (Figure 1.5.)33. The length of this sequence is variable
across different homologs of PKR and is virtually absent in PKR from Mesocricetus
auratus or golden Syrian hamster. The C-terminal region 229-258 is enriched in basic
residues and may possess some α helical content as predicted by secondary structure
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prediction algorithms. It is also relatively more conserved and contains the
phosphorylation site at 242.
The 90 residue linker region between the dsRBD and the kinase domain of PKR
is unstructured and is considered as an intrinsically disordered region based on full
length PKR structural studies using SAXS34 and NMR35. SAXS data obtained for PKR fit
best to a model where the protein exists in an ensemble of open and closed states
based on the end-to-end distance distributions. NMR studies with full length PKR have
also shown that residues within the linker produce spectra that are characteristic of
disordered proteins. There is some evidence to suggest that the linker may be involved
in dsRNA independent activation associated with dimerization. Constructs of the kinase
domain with the linker (169-551) were able to autophosphorylate at high concentrations
while constructs of the isolated kinase domain (252-551) were unable to become
activated at the same concentration range35.

Fig. 1.6. Sequence alignment of the linker from eukaryotic homologs of PKR.

	
  

1.6 Objectives and goals
PKR is activated upon binding dsRNA by dimerization and autophosphorylation. The
precise mechanism by which RNA binding stimulates activation is not clear. The active
kinase forms a back-to-back dimer where the active sites are on opposite ends of the
dimer. It is unclear how the autocatalytic pathway proceeds given the dimer
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configuration. It was previously assumed that dsRNAs that were long enough to
assemble more than one PKR monomer were activators. However certain RNAs can
bind two PKRs without activating. It is difficult to test if activation is blocked by an
inability to dimerize or by some other factor. Viral dsRNAs that interact with PKR in vivo
possess relatively short duplex regions interrupted by complex secondary structural
elements such as stem loops, internal loops and bulges. The mechanism by which PKR
is able to interact across these RNA barriers and dimerize is unclear. The current
methods available allow us to measure PKR assembly on dsRNA as well as activation.
However, we cannot measure the interaction between adjacent kinases on a dsRNA.
Formulating a protocol to measure PKR dimerization would allow us to confirm the
dimerization model and to determine if dimerization is the only pre-requisite for
activation.
1. Define the modes of PKR binding to variable length duplex RNAs.
Activation of PKR by longer dsRNAs is correlated with the interaction of the second
dsRNA binding motif (dsRBM). Mutants of PKR that lack the ability of the dsRBM2 to
bind dsRNA will be synthesized to investigate the role of this motif. The ability of the
mutants to bind to variable length dsRNAs will be determined using analytical
ultracentrifugation and PKR activation will be measured by autophosphorylation assays.
2. Investigate the effect of RNA barriers on PKR dimerization and activation.
RNA chimeras will be designed to contain two duplex PKR binding sites separated by
variable length inert barriers such as 2’-O-methyl modified RNA. They will be used as
molecular rulers to determine minimum barrier distance across which PKR can activate.
The stoichiometry and affinity of PKR binding and PKR activation will be measured
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using the techniques mentioned in Aim 1. The effect of other RNA barriers such as
internal loops and mismatched pairs will also be determined.
3. Define the role of the unstructured linker in PKR dimerization.
The 90 residue linker may be involved in enabling the kinase domains to dimerize over
barriers in dsRNAs such as internal loops and bulges. The ortholog of PKR from
Mesocricetus auratus (golden Syrian hamster) has a much shorter linker of about 20
residues. Hamster PKR will be expressed and purified and its ability to interact with
various length duplexes. In addition, linker-deleted constructs of human PKR will be
characterized to test the effect of linker length on PKR activation. SAXS STUFF
4.

Measure functional PKR dimerization using Förster resonance energy transfer

(FRET)
Some dsRNAs are able to bind two PKR monomers but are incapable of activating PKR. We will
directly assay dimerization of the kinase domain upon binding to activating and non-activating
RNAs to determine whether dimerization is correlated with PKR activation. Fluorescent probes
will be incorporated at specific sites near the PKR dimer interface by unnatural amino acid
mutagenesis. FRET will be used to assay PKR kinase domain dimerization upon binding to
RNAs. These studies will include the RNA chimeras and short duplexes mentioned in Aims 1
and 2.
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Chapter 2: Materials and Methods

2.1. Reagents, buffers and glassware
The buffer components and solvents used in the experiments were high purity reagent
grade chemicals. Buffers were filtered using 0.22 µm membranes and autoclaved.
TCEP was added to buffers immediately prior to use. Analytical ultracentrifugation cell
components were sonicated and treated with RNAaseZap (ThermoFischer Scientific).
Oligonucleotides used in the study were purchased from Dharmacon (Lafayette, CO).
Fluorescent dsRNA
20

25

30

35

40

TS40F - 5’-Fl GGAGAACUUCAUGCCCUUCG GAUAA GGACU CGUAU GUACC-3’
BS40 - 3’-

CCUCUUGAAGUACGGGAAGC CUAUU CCUGA GCAUA CAUGG-5’

Duplex dsRNA
20

25

30

35

40

TS40B - 5’- GGAGGAUGUUAAUUGGCGUG UCUUG UCUGC AACGG UAUUC - 3'
BS40B - 3’- CCUCCUACAAUUAACCGCAC AGAAC AGACG UUGCC AUAAG - 5’
2’-O-Methyl dsRNA
5Me

10Me

15Me

5’ - GGAGGAUGUUAAUUG mGmCmGmUmG mUmCmUmUmG mUmGmUmCmA
UCUGCAACGGUAUUC - 3’
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Table 2.1. RNA sequences

RNA

Molecular weight
(g/moles)

Mass extinction coefficient *
(L/g*cm)

Fl20 bp

13062.1

4.78E6

Fl25 bp

16477.1

2.53E6

Fl30 bp

19699.0

3.39E6

Fl35 bp

22905.0

3.49E6

Fl40 bp

27655.1

2.49E6

20B bp

13793.0

22.31

30B bp

19142.0

24.66

40B bp

25718.8

23.86

15-5Me-15

22509.0

23.75

15-10Me-15

25855.2

21.24

15-15Me-15

29201.5

27.5

*𝐌𝐚𝐬𝐬  𝐞𝐱𝐭𝐢𝐧𝐜𝐭𝐢𝐨𝐧  𝐜𝐨𝐞𝐟𝐟𝐢𝐜𝐢𝐞𝐧𝐭 =

𝐅𝐥𝐮𝐨𝐫𝐞𝐬𝐜𝐞𝐧𝐜𝐞  𝐨𝐫  𝐀𝐛𝐬𝐨𝐫𝐛𝐚𝐧𝐜𝐞  𝐢𝐧𝐭𝐞𝐧𝐬𝐢𝐭𝐲
𝐑𝐍𝐀   (𝐌)∗  𝐩𝐚𝐭𝐡  𝐥𝐞𝐧𝐠𝐭𝐡   𝐜𝐦 ∗  𝐌𝐨𝐥𝐞𝐜𝐮𝐥𝐚𝐫  𝐰𝐞𝐢𝐠𝐡𝐭  

𝐠
𝐦𝐨𝐥𝐞𝐬

(1)

2.2. Plasmids and site-directed mutagenesis
Single amino acid substitutions as well as deletions of human PKR were made using
the pET-PKR/PPase vector. Hamster PKR was cloned into pET28a upstream of lambda
phosphatase. Thermocycler from Biorad were used for all PCR reactions. All primers
were designed and purchased from Integrated DNA Technologies (IDT). Phusion High
Fidelity master mixes from New England Biolabs (NEB) were used for all PCR reaction
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preparations. The pEVOL-pAzF vector used for the expression of p-azidophenylalanine
(pAzF) specific amino-acyl tRNA synthetase (aaRS)/ tRNAUAG pairs was purchased
from Addgene.
2.3. RNA purification
The strands were deprotected and purified using polyacrylamide gel electrophoresis.
The RNA bands from the gels were cut and the RNA was extracted by electrolution
(Elutrap, G.E. Whatman). The RNA was precipitated using 3.5 M sodium acetate/ 99%
ethanol and dried using a Speed Vac centrifuge. The complementary strands were
annealed at 80°C for 5 minutes in either AU200 (20 mM HEPES, 200 mM NaCl, 0.1 mM
EDTA, pH 7.5) or AU75 (20 mM HEPES, 75 mM NaCl, 0.1 mM EDTA, pH 7.5) and
slowly cooled to room temperature before use. The extinction coefficient of the duplex
annealed strands was calculated and was usually ~10-25% lower than the sum of the
extinction coefficient of the individual strands owing to hypochromism. Sedimentation
velocity analysis was used to ensure that the dsRNAs were homogeneous.
2.4. Protein expression and purification
Human PKR constructs were transformed into Rosetta 2 pLyS cells and expressed as
described previously31. Hamster PKR was expressed and purified differently due to
reduced solubility. The pET-HamsterPKR/PPase vector was transformed into
ArcticExpress RIL (DE3) cells which express cold shock proteins Cpn 60 and Cpn 10.
Cells were grown at 37oC until OD600 was ~0.8 and hamster PKR was induced at 10oC
for 16 hours. PKR constructs containing amber stop codon substitutions were cotransformed with p-EVOL-pAzF in ArcticExpress RIL (DE3) cells. Cultures were grown
at 37oC and 250 rpm. The aaRS/ tRNAUAG pair were induced at an OD600 of 0.2-0.3 with
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0.02% arabinose. 1 mM pAzF (Bachem) was added 30 minutes after arabinose
addition. All subsequent steps were performed in the dark under non-reducing
conditions. 1 mM IPTG was added after cultures were cooled to 18oC, and induction
proceeded for four hours at room temperature. All PKR constructs were purified using a
two-step purification protocol as described previously. Concentrated PKR fractions were
separated from higher order aggregates by separation over size exclusion column (S200/S-75, G.E. Life Sciences) in AU200 buffer (20 mM HEPES pH 7.5, 200 mM NaCl
and 0.1 mM EDTA). Purified fractions were analyzed using SDS PAGE and
concentrated using Amicon Ultracentrifugal filters (EMD Millipore)
2.5. Fluorescent labeling of pAzF-PKR
Purified pAzF-PKR was labeled with Alexa fluor 488 DIBO (Molecular Probes) or Cy3
DBCO (Click Chemistry Tools). 10 mM stocks of the dyes were prepared in 99% DMSO
and stored at 4oC. Labeling reactions contained 25 µM PKR and 70 µM dye in AU200
buffer with a reaction volumes of 500 µL. Reactions were incubated for 1.5 hours at
room temperature and were quenched by buffer exchanging twice into AU200
containing 0.1 mM TCEP using spin columns containing P6 biogel beads (Biorad). The
efficiency of labeling was measured by recording the absorbance at 280 nm and 495
nm or 553 nm for Alexa 488 or Cy3 respectively.
!"#$%"&'()  !"  !"#  !"  !!"  !"

[Dye]= !"#$%&#$!"  !"#$$%&%#'(  !"  !"#∗!"#$  !"#$%&   (M)
[PKR]=

!"#$%"&'()  !"  !"#  !"  –   !"#$%"&'()  !"  !"#  !"  !!"  ∗  !.!.
!"#$%&#$'%  !"#$$%&%#'(  !"  !"#∗!"#$  !"#$%&

Labeling Efficiency =100% X [Dye]/[PKR]

	
  

(2)
(M)

(3)

(4)
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Where C.F. is the correction factor used to account for the contribution of the dye
absorbance at 280 nm. The C.F. for Alexa 488 is 0.11 and is 0.08 for Cy3. The
extinction coefficients used for human PKR, Alexa 488 and Cy3 were 43,400 M-1 cm-1,
71,000 M-1 cm-1 and 151,000 M-1 cm-1 respectively.
2.6. Sedimentation velocity experiments with PKR and dsRNAs
Absorbance detected sedimentation velocity analysis of PKR-dsRNA interactions was
performed in AU200 buffer at 20ºC using absorbance optics at 260 nm as previously
described36. Fluorescence sedimentation velocity experiments were performed using a
Beckman-Coulter

XL-I

analytical

ultracentrifuge

equipped

with

an

AU-FDS

Fluorescence detector (AVIV Biomedical, Lakewood, NJ) at 20°C and 40,000 rpm
unless specified. Samples contained 20-30 nM dsRNA and varying concentrations of
PKR in either AU200 or AU75 buffer were loaded into double sector cells equipped with
1.2 cm Spin60 charcoal-epon centerpieces (Spin Analytical, Berwick, ME) and quartz
windows. During a pre-run at 5,000 RPM the photomultiplier voltage and gain multiplier
settings were adjusted to give ~ 3000 counts and the focus depth was set to give a
maximum signal. Absorbance intensity scans were recorded for each channel following
the sedimentation velocity experiment and the meniscus position was determined from
a characteristic downward intensity spike.
The protein partial specific volume and the buffer densities and viscosities were
calculated using SEDNTERP. The partial specific volumes of the dsRNAs were fixed at
0.55 ml g-1. The sedimentation velocity data for the dsRNAs were first analyzed using a
c(s) distribution model with Sedfit to ensure that the preparations were homogenous
and free of contaminants. The data were then fit to a single species model to obtain the
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sedimentation coefficients and the buoyant molar masses that were then fixed in
subsequent global analyses of PKR binding. Sedimentation velocity analyses of PKRdsRNA interactions were performed as previously described with some modifications to
accommodate fluorescence data as described below. Initially, the data were analyzed
using the time derivative method with DCDT+ to obtain g(s*) distributions to define the
interaction model. Model-dependence global analysis was performed using SEDANAL
to define the association constants and sedimentation coefficients of the protein-RNA
complexes. For data acquired with the fluorescence detector, the amplitude of the
stochastic noise depends strongly on the signal intensity. Therefore, the curve fits were
weighted by the standard deviation at each point. This also served to convert the RMSD
reported by SEDANAL from arbitrary fluorescence intensity units to χ, where a value of
1.0 corresponds to a perfect fit. Joint confidence intervals were obtained using the Fstatistic to define a statistically significant increase in the variance.

2.6. Sedimentation equilibrium analysis of PKR
Sedimentation equilibrium analysis of PKR self-association was performed in AU200 at
20ºC or 4ºC as indicated using Rayleigh interference optics.

Six-channel external

loading cells were used at rotor speeds of 18,000, 22,000, 28,000 rpm. Scans of water
blanks were collected at each speed prior to running PKR samples. The blank scans
were subtracted from the samples and data were analyzed using HETEROANALYSIS37.
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2.7. PKR activation
Quantitative phosphorylation assays were carried out as previously described by
incubating 200 nM PKR with varying concentrations of dsRNA in AU75 buffer containing
5 mM MgCl2 and 0.1mM TCEP at 32 °C for 20 minutes. The phosphorylation reactions
were initiated with 0.4 mM ATP containing 4 µCi [γ-32P] ATP in each reaction mixture
and were quenched after 20 minutes by adding SDS sample loading buffer unless
indicated otherwise. The reaction mixtures were then heated to 90 °C for 3 minutes and
were analyzed using SDS PAGE electrophoresis and phosphor imaging (Typhoon, GE
Healthcare).
2.8. Steady state fluorescence anisotropy measurements
Steady state fluorescence anisotropy and emission measurements were recorded with
a FluoroMax-3 fluorimeter equipped with Glan-Thompson polarizers (Jobin Yvon Inc.,
New Jersey). All measurements were performed at 20ºC with samples in either AU200
or AU75 buffer using a 10 mm path length quartz cuvette (Precision Cells).
Fluorescence anisotropy measurements were performed with Alexa 488-labeled
PKR at excitation and emission wavelengths of 495 nm and 518 nm and bandwidths of
2 and 3 nm, respectively. Intensities were integrated at each polarization for 5 s with
three repetitions. The data were corrected for buffer background and the anisotropy (r)
was calculated as

r=

I! − GI⊥
I! + 2GI⊥

(4)

where Iǁ‖ and I⊥ correspond to the fluorescence intensity with the excitation polarizer
oriented in the vertical position and the emission polarizer in the vertical and horizontal
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positions, respectively. The G factor corrects for instrument polarization bias and was
measured to be ~0.64.
In a cluster of identical molecules undergoing Homo-FRET, the emission is the sum
of the contribution of the initially excited chromophore and the other chromophores.
Energy transfer-induced depolarization of the emission and several expressions have
been derived for the steady state anisotropy expected for a dimeric cluster. The results
are very similar; here, we use the formalism of Runnels and Scarlatta.
The total anisotropy of the dimeric cluster (rtot) is the sum of the anisotropy of the
initially excited chromophore (r1) and the anisotropy of the molecule excited by energy
transfer (ret)38

rtot = r1

⎛R ⎞
1+ ⎜ 0 ⎟
⎝ R⎠

6

⎛R ⎞
1+ 2 ⎜ 0 ⎟
⎝ R⎠

(R R )
1+ 2 ( R R )
6

6

+ rET

0

6

(5)

0

where R0 is the Förster distance and R is the distance between the chromophores.
In the case of a dimeric cluster with random relative orientation of the chromophores,
energy transfer results in complete depolarization such that ret = 0. Even in the case of
rigid, parallel emission and excitation dipoles, ret is only 0.016. For pAzF261-A488 r1 =
0.2869, and for the PKR dimer in the back-to-back, antiparallel orientation, R = 25 Å
(Figure 1B). R0 for Alexa Fluor 488 self-transfer is 48 Å39 and equation S1 (assuming
ret=0) predicts rtot = 0.145, or about half the monomer value. An antiparallel PKR dimer
model was constructed by aligning the PKR kinase (PDB accession 2A1A) onto the
GNC2 dimer structure (PDB accession 1ZYC) using interface residues conserved
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between PKR and GCN2. In this case, the inter-chromophore distance increases to R =
49 Å and rtot = 0.195, or about 2/3 of the monomer.

2.9. Small angle X-Ray scattering (SAXS) of ΔV PKR
SAXS measurements were performed in AU200 buffer at 4oC using a Nanostar
instrument (Bruker, Madison, WI) equipped with a rotatating anode source and 550 µm
scatterless pinholes. Proteins were centrifuged at 14,000 rpm for 10 minutes prior to
measurements. Data were collected in four 1 h frames at a sample-detector distance of
67.2 cm proving a range of q = 0.007- 0.37 Å-1. Data were reduced using Bruker SAXS
software. The four scans overlayed, indicating the absence of radiation damage. Buffer
background scattering (15 1 hour frames) was subtracted from the data prior to
analysis. Guinier analysis was performed using the low-q portion of the data where
Rg•q<1.3. The p(r) distributions were produced using GNOM and the maximum
dimension (Dmax) was manually adjusted to the distance where the p(r) distribution
approaches zero. Structural modeling was performing using EOM 2.0. The program
generated a pool of 10,000 possible scattering intensities using the Ranch software.
Then a genetic algorithm was applied to obtain a distribution which represents the
ensemble that fit best to the experimentally obtained scattering curve for the protein.
The ensemble distribution was for a default set of curves as decided by the algorithm.
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Chapter 3: Effect of salt concentration on PKR-dsRNAs binding

3.1. Introduction
Protein kinase R (PKR) is an important component of the interferon-induced innate
immune pathway3. PKR is synthesized in the cell in a latent, unphosphorylated form and
becomes activated and undergoes autophosphorylation upon binding to certain host or
pathogen associated RNAs or upon interacting with the protein PACT. Activated PKR
phosphorylates eukaryotic Initiation Factor 2α (eIF2α), causing an inhibition of protein
synthesis. Many viruses have developed mechanisms to inhibit PKR40.
PKR contains an N-terminal dsRNA binding domain and a C-terminal kinase
domain, separated by a flexible linker region. The N-terminal dsRNA binding domain
(dsRBD) corresponds to the regulatory domain which consists of two tandem copies of
the dsRNA binding motif, dsRBM1 and dsRBM2. This motif binds duplex RNA in a nonsequence specific manner but discriminates against ssRNA and dsDNA41. Each motif
adopts the conserved αβββα18 fold and they are separated by an unstructured linker of
~20 amino acids. The crystal structure of a dsRNA-binding domain complexed with
dsRNA reveals a3 site size of 16 bp11. The C-terminal kinase domain is the catalytic
center. The crystal structure of the PKR kinase domain in complex with eIF2α reveals
that the catalytic center has the canonical protein kinase fold. The complex forms a
dimer where the interface is in the N-terminal lobe of the kinase domain17.
PKR is regulated by a variety of cellular and viral RNAs that contain duplex
regions42. The most well characterized activators of PKR are simple dsRNAs. There is
strong evidence that dimerization plays a crucial role in the mechanism of PKR
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activation by dsRNA5,43. Latent PKR dimerizes weakly in solution but this reaction is
sufficient to activate PKR in the absence of RNA31. An allosteric pathway has been
identified that couples the dimer interface with the kinase active site and dimer interface
mutations can modulate PKR activation17,44. A hallmark of PKR activation by dsRNA is
the

“bell-shaped” curve where low RNA concentrations activate but higher

concentrations are inhibitory12,15. These observations support a model in which multiple
PKRs assemble on a single dsRNA and high dsRNA concentrations dilute PKR
monomers onto separate molecules of dsRNA45. In the context of regular duplex RNA,
a minimum of 30-33 bp of dsRNA are required to activate PKR autophosphorylation and
the maximal level of activation increases with duplex length12,13. .
The mechanism of assembly of PKR on duplex RNAs has been extensively
investigated. PKR can bind to duplexes as short as 16-18 bp19,20. As expected for a
non-sequence specific interaction, the binding stoichiometry increases with dsRNA
length12,13,19,20.

The binding stoichiometries for the dsRBM1 and for a construct

containing dsRBM1 and dsRBM2 are greater than predicted from the site size20,46.
Based on these results, we proposed an overlapping ligand binding model where the
motif binds to multiple faces of the dsRNA duplex and overlaps along the helical axis.
The increase in binding affinity with increasing dsRNA length can be understood as a
statistical consequence of the greater number of configurations available on the longer
lattice. The intrinsic binding affinities of a dsRBM1-dsRBM2 construct and full length
PKR for a 20 bp RNA are similar13,20 but the stoichiometries are lower for the latter. A
minimum of 30 bp of dsRNA are required to bind two full length PKR monomers with
high affinity, which correlates with the minimal dsRNA capable of activating through
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autophosphorylation.

Binding affinities increase dramatically upon reducing the salt

concentration from 200 to 75 mM NaCl and a second PKR can bind to 20 bp duplex at
lower salt13.
The non-sequence specific interactions of PKR with RNAs are labile and it is
important to use solution biophysical methods to accurately measure the binding
parameters at thermodynamic equilibrium. Our previous analyses of PKR binding to
dsRNA by sedimentation velocity analytical ultracentrifugation13,31 were limited by
formation of nonspecific aggregates, even at the minimal RNA concentrations required
for detection using absorption optics. Aggregation is enhanced for longer RNAs and at
lower salt concentrations. In addition, it is difficult to quantify high affinity binding
constants due to the limited sensitivity of the absorbance optics. Here, we have used
fluorescence detection of labeled dsRNAs to enhance the sensitivity of sedimentation
velocity measurements and directly characterize the interaction of PKR with duplex
RNAs ranging from 20-40 bp and at multiple salt concentrations. The binding affinities
increase at lower salt concentration and with longer dsRNA length, and in some cases
the stoichiometries of binding of PKR to dsRNA increase at 75 mM NaCl. The
dependence of the binding stoichiometries on dsRNA length does not conform to
standard statistical models for nonspecific binding. We propose a model where the
activation of PKR by longer RNAs is correlated with an alternative binding mode that
allows for direct interaction of the kinase domains.
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3.2. Results
3.2.1. Sedimentation velocity of PKR and various length duplexes
The enhanced sensitivity of fluorescence detection in sedimentation velocity
measurements allows the dsRNA concentrations to be greatly reduced, from ~1 µM
using absorbance detection at 260 nm to 20-30 nM for fluorescence analysis of 5'fluorescein labeled RNAs. Figure 3.1. shows an analysis of PKR binding to dsRNA
using a long sequence (40 bp) at low salt (75 mM NaCl), conditions that previously were
found to promote aggregation. The signal/noise of the raw sedimentation velocity traces
for the RNA alone is excellent (Figure 3.1.A). The data fit well to a model of a single
species with a corrected sedimentation coefficient of s20,w = 3.69 S and a molecular
weight of 30,979 g/mol consistent with a predicted mass of 26,128 g/mol based on the
RNA sequence. Thus, this dsRNA preparation is homogenous and suitable for analysis
of PKR binding.
The binding of PKR to the 40 bp dsRNA was characterized by a sedimentation
velocity titration using fluorescence detection. Although the general approach is similar
to the method we have previously described by analysis of PKR-RNA interactions using
absorbance detection36, the RNA concentration here is much lower and we are able to
access a much broader range of PKR concentrations, ranging from nM to µM. Another
difference is that the PKR contributes, albeit weakly, to the absorbance signal measured
at 260 nm whereas only the fluorescein-labeled RNA contributes to the fluorescence
signal.
Initially, the velocity data are analyzed using a model-independent approach to help
define the correct binding mode. Figure 3.1.B shows a titration of the 40 bp dsRNA over
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a broad range of PKR concentration from 50 nM to 7 µM, represented as an overlay of
normalized g(s*) sedimentation coefficient distributions. The formation of PKR-dsRNA
complexes causes the distributions to shift far to the right, to a saturating value of ~ 9.46
S at 2 µM PKR. Hydrodynamic calculations indicate that the magnitude of this shift is
greater than expected for binding of a single PKR but is consistent with binding of three
PKR monomers (Table 3.2.). The g(s*) distribution at 7 µM exhibits a shoulder at higher
S, indicating formation of higher aggregates. However, the data obtained over the range
50 nM - 2 µM can be globally fit to a sequential binding model to resolve the three
equilibrium constants (Figure 3.1.C). The fit is of good quality, with small systematic
deviations in the residuals and RMSD = 1.70. As we have previously observed for PKR
binding to dsRNA lattices13,20,46, the first PKR binds most strongly, with Kd1 ~30 nM and
the second and third ligand bind progressively more weakly, with Kd2 ~ 50 nM and Kd3 ~
250 nM Table 3.1.). Note that these are stepwise, macroscopic dissociation constants
and are not corrected for statistical effects. Fitted values for the sedimentation
coefficients of the three complexes RNA-PKR, RNA-PKR2 and RNA-PKR3 (Table 3.2.)
correspond to frictional ratios of 1.42, 1.46, and 1.40, respectively, which lie in the range
typically observed for RNA-PKR complexes36.
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Figure 3.1. Sedimentation velocity analysis of PKR binding to a 40 bp dsRNA in AU75.
(A) Raw sedimentation velocity profiles for 40 bp dsRNA. For clarity, only every 13th
scan is shown. (B) Normalized g(s*) distributions of 0.03 µM 40 bp dsRNA (black),
dsRNA + 0.05 µM PKR (blue), dsRNA + 0.3 µM PKR (red), dsRNA + 0.8 µM PKR
(cyan), dsRNA + 2 µM PKR (green), dsRNA + 7 µM PKR (brown). (C) Global analysis of
difference curves. The data were subtracted in pairs to remove systematic noise and
the four data sets at the PKR concentrations were fit to a 2:1 binding model using
SEDANAL. The top panels show the data (points) and fit (solid lines) and the bottom
panels show the residuals (points). The best-fit parameters are shown in Table 3.1. For
clarity, only every 7th difference curve of the 165 scans that were fit is shown.
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Table 3.1. PKR-dsRNA dissociation constants measured in AU75 and AU200
buffers at 20°C.
dsRNA

[NaCl]

Model

(bp)

mM

a

20

75

2

20

200

1

25

75

2

25

200

1

30

75

2

30

200

2

35

75

2

35

200

2

40

75

3

40

200

2

Kd1 (nM)

Kd2 (nM)

45.2

54.1

(35.2, 59.5)

(40.9, 69.9)

303

-

(263, 349)
7.8

473

(6.8, 9.0)

(391, 572)

438

-

(380, 497)

Kd3 (nM)

RMSD
b

-

1.54

-

1.50

-

1.83

-

1.27

-

1.54

-

1.31

-

1.67

100.1

22.6

(83.1, 122.5)

(18.6, 26.8)

52.0

6270

(46.0, 58.3)

(3920, 11800)

7.6

69.1

(6.7, 8.6)

(50.8, 95.2)

61.1

4910

(47.9, 72.8)

(2950, 8260)

32.1

52.4

245

(27.3, 38.0)

(40.6, 67.8)

(212, 280)

38.1

813

(29.5, 47.3)

(645, 1070)

1.38

-

1.70
1.52

Parameters were obtained by global nonlinear least square analysis of sedimentation velocity
experiments. The values in parentheses represent the 95% joint confidence intervals obtained
using the F-statistic.
a
b

The model is specified by the stoichiometry of PKR binding.
The root mean square deviation of the fit. Because the fits were weighted by the standard

deviation of the data at each point, a perfect fit corresponds to an RMSD of unity.
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Table 3.2: Hydrodynamic parameters for dsRNAs and dsRNA-PKR complexes.
dsRNA
(bp)
20

PKR:dsRNAa
0:1

[NaCl]
mM
75

Molecular Mass
(g/mol)
13285.2

2.42

s20,w
(S)
2.48

1.58

20

1:1

200

75380.2

4.73

5.00

1.39

20

1:1

75

75380.2

4.83b

5.00

1.39

20

2:1

75

137475.2

6.26

6.47

1.61

25

0:1

75

16474.1

2.79

2.86

1.67

25

1:1

200

78569.1

4.80

5.07

1.53

25

1:1

75

78569.1

4.91b

5.07

1.53

25

2:1

75

140664.1

6.79

7.02

1.53

30

0:1

75

19699

3.05

3.12

1.72

30

1:1

200

81794.0

5.22

5.51

1.47

30

1:1

75

81794.0

5.33b

5.51

1.47

30

2:1

200

143889.0

7.49

7.92

1.39

30

2:1

75

143889.0

7.68

8.02

1.39

35

0:1

75

22905.9

3.27

3.36

1.75

35

1:1

200

85000.9

5.81

6.12

1.38

35

1:1

75

85000.9

5.93b

6.12

1.38

35

2:1

200

147095.9

7.32

7.73

1.47

35

2:1

75

147095.9

8.22

8.49

1.33

40

0:1

75

26127.9

3.59

3.69

1.76

40

1:1

200

88222.9

5.97

6.29

1.42

40

1:1

75

88222.9

6.03b

6.29

1.42

40

2:1

200

150317.9

7.65

8.08

1.46

40

2:1

75

150317.9

7.73b

8.08

1.46

40

3:1

75

212412.9

9.77

10.10

1.40

s (S)

f/fo

a

The ratio of PKR to dsRNA in each complex.

b

The sedimentation coefficient in AU75 could not be obtained from global analysis in SEDANAL

and was fixed based on the corresponding value obtained in AU200.
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These results obtained with the 40 bp dsRNA in AU75 demonstrate that it is feasible
to analyze PKR binding to relatively long dsRNAs, even at low ionic strength, by
reducing the dsRNA concentration into the nM range using the high sensitivity afforded
by fluorescence detected analytical ultracentrifugation. We have employed this
approach to rigorously define the PKR binding stoichiometries and affinities for a
truncation series of dsRNAs ranging from 20 to 40 bp in 5 bp increments. Binding
parameters were obtained at both high (200 mM) and low (75 mM) concentrations of
NaCl. As described above for the 40 bp duplex, the binding stoichiometries were based
on the limiting sedimentation coefficients estimated from the shift in g(s*) distributions
with increasing PKR concentration. The models were verified and binding constants
were resolved by global analysis of the data using SEDANAL. For the measurements
performed in 75 mM NaCl, where the binding affinity is high, it was not possible to
reliably fit for the sedimentation coefficients of the intermediate dsRNA-PKR complexes
due to low population of these species.

The sedimentation coefficients for these

species were fixed at the values obtained in 200 mM NaCl (corrected for buffer density
and viscosity). The results of the fits are summarized in Table 3.1. and the
corresponding hydrodynamic parameters are presented in Table 3.2.
There are several trends that emerge from the analysis of PKR binding to the RNA
truncation series at high- and low-salt conditions. For several of the dsRNAs (20, 25 and
40bp) the apparent binding stoichiometries increase at lower salt. This effect is likely
associated with the enhancement in binding affinity that occurs at lower salt19. The Kds
decrease by as much as 10-fold upon reducing [NaCl] from 200 to 75 mM. Thus, the
second (20 and 25 bp) or third (40 bp) PKR is not detectable at high salt because Kd
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becomes too high. In most cases, the dissociation constants sequentially increase such
that Kd1<Kd2<Kd3.

This successive decrease in binding affinities is not due to a

negative cooperativity but represents a statistical effect. The macroscopic, stepwise
binding constants measured in sedimentation velocity experiments correspond to the
product of an intrinsic binding constant k and a statistical factor corresponding to the
number of microscopic configurations of the ligand on the dsRNA46,47. As the RNA is
sequentially saturated with ligand the statistical factors decrease, resulting in
successively weaker binding. As expected for a nonspecific protein-nucleic acid
interaction, the limiting binding stoichiometries measured in AU75 increase with the
length of the dsRNA. However, this trend is surprisingly weak: upon doubling the lattice
length from 20 to 40 bp the number of PKRs that bind does not double and only
increases from 2 to 3.
3.2.2. Activation of PKR by duplexes in low salt
It has previously been reported that activation of PKR requires a minimum of 30 bp
of dsRNA12 and we have correlated PKR activation with the stoichiometry of binding
measured in AU200 buffer for the dsRNA truncation series13. Our PKR binding data
indicate a strong dependence of binding stoichiometry on salt concentration. Thus, we
have re-examined the dependence of PKR activation of dsRNA length in a lower salt,
AU75 buffer (Figure 3.2.). The activation profiles are very similar to those we previously
observed at higher salt. A minimum of 30 bp are required to detect activation with a
maximum near 30 nM and the maximal extent of activation increases with the length of
the dsRNA. Thus, although the 20 and 25 bp dsRNAs can each bind two PKRs in
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AU75 buffer, they are incapable of stimulating autophosphorylation under the same
conditions.

Figure 3.2.

Activation of PKR by varying length duplex RNAs in 75 mM NaCl.

Experiments were performed as previously described (10) in AU75 buffer at 32°C. Each
reaction contains 200 nM PKR, 0.4 mM ATP, 4 µCi [γ-32P]-ATP and the indicated
amount of RNA. The reaction was allowed to proceed for 20 min at 32°C before
quenching with SDS loading buffer and resolved on SDS-PAGE. 20bp dsRNA (black),
25bp dsRNA (blue), 30bp dsRNA (red), 35bp dsRNA (green), 40bp dsRNA (brown)
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Figure 3.3. Model for PKR binding to short and long dsRNAs. (A) Domain organization
of PKR. (B) Two PKRs are able to bind to the 20 bp dsRNA at low salt via dsRBM1.
PKR binds to dsRNAs of ≥ 30 bp with a larger site size via interaction of both dsRBM1
and dsRBM2. This binding model facilitates dimerization of the kinase domains,
resulting in PKR activation.
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Discussion
The

enhanced

sensitivity

afforded

using

fluorescein-tagged

dsRNAs

with

fluorescence-detected analytical ultracentrifugation has allowed to us greatly reduce
RNA concentrations from micromolar to nanomolar. In contrast to previous studies of
PKR-dsRNA interactions by analytical ultracentrifugation13, at lower RNA concentrations
the analysis of binding stoichiometries and affinities is not complicated by aggregation
formation and we were able to directly characterize the interaction of PKR with duplex
RNAs ranging from 20-40 bp at multiple salt concentrations. The binding stoichiometries
obtained here at 200 mM NaCl agree with those obtained earlier except for the 40 bp
dsRNA, where we previously detected three PKR ligands by fluorescence anisotropy
and sedimentation equilibrium13 but only two in the present sedimentation velocity
measurements. Note that sedimentation velocity has greater resolving power than the
earlier techniques and small amounts of aggregate may have contributed to a higher
apparent stoichiometry. The dissociation constants for the 20 and 30 bp dsRNAs in 200
mM NaCl differ slightly from those previously obtained using absorbance detection. The
origin of the discrepancies is not clear but the broader PKR concentration range used
for the present experiments make them more reliable.
The dependence of the PKR binding stoichiometries and affinities on salt
concentration and RNA length provides insight into the mechanism of assembly of PKR
on duplex RNAs and formation of active complexes.

There is a large electrostatic

component to the PKR-dsRNA interaction19 that results in increased binding affinity as
the NaCl concentration is decreased from 200 to 75 mM. The concomitant increase in
binding stoichiometries for several of the RNAs is likely associated with the

	
  

34

enhancement in binding affinity. Limited solubility of PKR-RNA complexes precludes
measurements at NaCl concentrations below 75 mM and we make the assumption that
the stoichiometries measured under these conditions correspond to the maximum. We
have previously characterized the binding of the PKR dsRBD, containing both dsRBM1
and dsRBM2, and dsRBM1 alone to the same dsRNA truncation series in AU75
buffer20,46. The stoichiometries for the full-length enzyme are consistently lower for
either domain construct across the range of RNA lengths. Presumably, the presence of
the kinase domain and linker in PKR result in steric hindrance, which increases the
effective binding site size relative to the domain constructs.
The dependence of the limiting PKR binding stoichiometries on dsRNA length does
not conform to standard models for nonspecific binding of proteins to finite nucleic acid
lattices48-50. The stoichiometries are expected to regularly increase with RNA length,
but for PKR they remain fixed at 2 PKR/RNA from 20-35 bp and only increase to 3 for
the 40 bp sequence. In contrast, the stoichiometries for dsRBM1 binding to RNA
increase strongly with length and conforms to a modified overlapping ligand binding
model46 where the motif binds to multiple faces of the dsRNA duplex and overlaps along
the helical axis with a site size of 12 bp and a minimum overlap of 4 bp20. The dsRBD
also follows this model for RNAs up to a length of 30 bp but deviates strongly for longer
RNAs, and the stoichiometries actually decrease between 35 and 40 bp. These data
indicate a change in binding mode to a larger size with increasing RNA length. This
model is supported by NMR mapping experiments showing that only the N-terminus of
dsRBM2 interacts with a 20 bp dsRNA but extensive interactions are observed upon
binding to the 40 bp sequence20. In addition, affinity cleavage experiments demonstrate
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that simultaneous binding of both dsRBMs of PKR is correlated with PKR activation51.
We suggest that an analogous change of binding mode occurs as a function of RNA
length for the full-length enzyme, resulting in an increase in the site size and a constant
binding stoichiometry from 20-35 bp.
Although dimerization clearly plays a critical role in the PKR mechanism43, the
ability of a single dsRNA to bind 2 PKR monomers is not sufficient to induce
autophosphorylation. In AU75 buffer the 20 and 25 bp RNAs each bind 2 PKRs yet are
incapable of inducing measurable autophosphorylation (Figure 3.2.). Previously, we
suggested that the inability of these shorter RNAs to activate in AU200 is associated
with low binding affinities, resulting in low population of the active (PKR)2:RNA
species13. However, the 20 and 25 bp RNAs also do not activate in AU75, yet the
binding affinities measured in this buffer are as strong as those measured for a 30 bp
RNA in AU200 where this RNA is capable of activating PKR autophosphorylation. Thus,
additional factors must be limiting the ability of short RNAs to induce the functional,
active dimeric form of PKR. We propose that activation of PKR by longer RNAs requires
a binding mode that inaccessible upon binding to shorter RNAs (Figure 3.3.). Our RNA
binding data indicate that this active binding state is characterized by a larger size.
Possibly, this mode is required to allow for direct interaction of the kinase domains to
mediate functional dimerization.
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Chapter 4: Assaying PKR dimerization

4.1. Introduction
The N-terminal regulatory module of PKR consists of two dsRNA binding domains
(dsRBDs)18. Although the PKR dsRBDs bind dsRNA without sequence specificity19,
there is evidence for shape recognition and sequence readout in the minor groove in
some other dsRBDs52. The catalytic domain has the typical bilobal architecture found in
protein kinases, consisting of a smaller N terminal (N-) lobe and a larger C terminal (C-)
lobe17.
A key mechanistic issue is how interaction of the PKR dsRBDs with dsRNA leads to
activation of the kinase. Early studies supported an autoinhibition model in which the
latent form of PKR is locked in a closed conformation where the second dsRBD
interacts with the kinase and blocks substrate binding43. In this scenario, RNA binding
to the dsRBDs leads to an open, active state. This view is supported by NMR chemical
shift perturbation measurements that reveal interaction between the second dsRBD and
the kinase53,54. However, this interaction is extremely weak (Kd ~ 250 µM)55. SAXS34,
AFM56 and NMR35 analysis of latent PKR reveal that the long (~90 amino acid) linker
between the dsRBDs and the kinase domain is flexible and unstructured, giving rise to a
range of open and closed conformations that is inconsistent with the autoinhibition
model.
An emerging mechanism in the regulation of protein kinases is the allosteric linkage
of dimerization with a conformational transition to an active state57. Structural and
biophysical analyses support a pivotal role for dimerization in activation43. The PKR
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kinase domain forms a dimer in both active, phosphorylated17 and inactive state58.
PKR dimerizes only weakly (Kd ~ 500 µM); however, this reaction is sufficient to activate
autophosphorylation in the absence of dsRNA31. In the context of duplex RNA, the
minimum length of ~30bp of duplex required to activate PKR

12,13

correlates with the

minimum length capable of binding two PKR monomers with high affinity59. PKR
activation exhibits a characteristic bell-shaped curve where high dsRNA concentrations
inhibit12, consistent with a model where PKR dimers are dissociated by dilution onto
separate dsRNAs45. These results support a PKR activation model where RNA binding
functions to bring two kinase domains into close proximity and facilitate dimerization.
Dimerization plays a role in the activation of other eIF2α kinases. PERK
dimerization is linked to activation60 whereas HRI61 and GCN262 exist as constitutive
dimers. The structure of a phosphorylated PERK kinase domain reveals a back-to-back
parallel dimer similar to PKR63. Although a similar N-lobe dimer interface is observed in
a structure of an unphosphorylated GCN2 kinase domain, it adopts a novel, antiparallel
orientation where one subunit is rotated approximately 180º64. Interdimer hydrogen
bonding (Y323-D289) and salt-bridge (R262-D266) residues are conserved within the
family. Mutations designed to disrupt the salt-bridge in PKR, GCN2 and PERK block
kinase activity and charge reversal restores biological function44,65,66. This contact is
formed in the parallel PERK dimer, but the corresponding residues are too far apart in
the antiparallel GCN2 dimer to form a salt bridge. The antiparallel GCN2 dimer likely
corresponds to an inactive conformation and activation may be associated with rotation
to a parallel structure that results in formation of the essential salt-bridge57,64.
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Interestingly, simultaneous binding of two or more PKRs to an RNA does not
necessarily activate. For example, at low salt two PKRs can bind RNAs as short as 20
bp

without

inducing

autophosphorylation59.

Typical

protein-RNA

interaction

measurements can count the number of protein monomers bound to an RNA but cannot
determine whether the proteins directly interact on the RNA to form a dimer. Thus, we
have developed a sensitive fluorescence assay to direct probe the role of PKR kinase
domain dimerization in RNA-induced activation. We observe efficient dimerization upon
binding to activating duplex RNAs. Surprisingly, several non-activating RNAs that bind
multiple PKRs also induce dimerization. We propose that PKR can adopt an alternative,
non-activating dimer configuration.

4.2. Results
4.2.1. Characterization of pAzF-261-A488
A homo-Förster Resonance Energy Transfer (homo-FRET) fluorescence assay was
developed to directly monitor dimerization of PKR kinase domains induced by RNA
binding.

Homo-FRET occurs between fluorophores of the same kind provided the

Stokes shift is small, and is readily detected by depolarization of the emission using
steady-state anisotropy measurements. Based on the dsRNA dissociation constants for
PKR59, the equilibrium populations of PKR dimers are expected to be low and we have
used homo-FRET to assay PKR kinase domain dimerization due to the high precision of
the measurement and convenience of labeling. Because PKR contains 8 cysteines, 7
of which are highly conserved, unnatural amino acid mutagenesis67 was employed to
introduce a single p-azido phenylalanine (pAzF) residue into wild-type PKR for labeling
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with extrinsic fluorophores (Fig. 4.2.A.). Labeling sites were selected based on their
proximity, solvent accessibility, and lack of interference with the dimer interface. Highly
conserved residues were excluded. The K261pAzF mutant was chosen for detailed
analysis based on high expression, ease of labeling, and efficient homo-FRET.
K261pAzF PKR reacts readily with Alexa Fluor 488-dibenzocyclooctyne to produce
a stable conjugate, denoted pAzF-261-A488. The integrity of the labeled protein was
monitored by autophosphorylation assays, dsRNA binding, and solution dimerization
analysis. pAzF-261-A488 is an active kinase and undergoes autophosphorylation upon
addition of a 40 bp dsRNA at a level about 2.5 -fold higher than unlabeled PKR (Fig.
4.1.A). As previously observed for unlabeled PKR13,59, two monomers of pAzF261A488 bind to the activating 40 bp dsRNA with comparable dissociation constants (Fig.
4.1.B). As assayed by sedimentation equilibrium experiments in the absence of RNA,
pAzF261-A488 PKR undergoes reversible dimerization with Kd = 94 (85, 103) µM
(Figure 4.1.C) which is ~5 fold lower than the Kd for dimerization of unlabeled PKR31.
The enhancement in activation of pAzF-261-A488 relative to unlabeled PKR may be
due to the tighter dimerization. This enhancement in dimerization is not observed for
PKR labeled at position 371, which is more distant from the dimer interface (Kd = 1,260
µM). However, the energy transfer efficiency is too low for useful analysis. For the pAzF261-A488 dimer, the predicted inter-chromophore distance is R = 25 Å (Figure 4.2.B)
and R0 for Alexa Fluor 488 is 48 Å39, with a corresponding energy transfer efficiency is
98% and a steady-state anisotropy about half the monomer value.
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Figure 4.1.: Characterization of pAzF-261-A488. (A) Activation of pAzF-261-A488 by
40 bp dsRNA. Top: Phosphorimager analysis of unlabeled PKR (red) and pAzF-261A488 (blue) activation. Bottom: quantitation. Data were normalized to unlabeled PKR at
30 nM 40 bp. (B) Sedimentation velocity analysis of pAzF-261-A488 binding to 0.75 µM
40 bp dsRNA. Global analysis of difference curves for at three concentrations of pAzF261-A488 fit to a 2:1 binding model provides best-fit dissociation constants of Kd1=
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0.324 (0.280, 0.376) µM and Kd2 = 0.517 (0.448, 0.579) µM with RMSD = 0.0060 OD.
The top panels contain the data (points) and fits (lines) and the bottom panels contain
the residuals. (C) Sedimentation equilibrium analysis of pAzF-261-A488 selfassociation. Global analysis of 5 concentrations and two rotor speeds (18000 rpm –
blue, 28000 rpm – red) to a monomer-dimer model results in Kd = 94 (85, 103) µM with
RMSD = 0.0327 fringes. (D) Fluorescence anisotropy analysis of pAzF-261-A488
dimerization in the absence of dsRNA.

Top: raw anisotropy as a function of

concentration. Bottom: experimental % dimer calculated from the anisotropy data
compared to the % dimer predicted using the Kd determined by sedimentation
equilibrium of 94 µM. The slits were adjusted during the titration to maintain the count
rate in the linear range.

4.2.2. PKR Dimerization by duplex RNAs
Significant anisotropy changes are induced by binding of pAz-F261-A488 to duplex
RNAs (Fig. 4.2.C). The anisotropy decreases upon addition of dsRNAs ≥ 30 bp capable
of activating PKR and binding two or more monomers, but non-activating, 20 and 25 bp
duplexes that bind a single PKR produce negligible anisotropy changes60. Thus, RNA
binding alone does not significantly affect the steady state anisotropy of pAzF261-A488,
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and the depolarization induced upon addition of the longer duplexes can be ascribed to
homo-FRET within kinase domain dimers. Note that the dsRBD is separated from the
kinase domain by a long (~ 90 residue) unstructured linker, so that the changes in
rotational correlation time of the dsRBD due to RNA binding are not expected to affect
the kinase.
Quantitative analysis of the anisotropy changes produced by the activating dsRNAs
provides useful mechanistic insights. The amplitude of the anisotropy change increases
with the length of the dsRNA, but even for the longest (40 bp) RNA the maximum
decrease of 12% does not approach the ~50% effect predicted by theory. Also, the
anisotropy returns to the monomer value at higher RNA concentrations. This behavior is
consistent with a simulation of the sequential binding equilibria for pAzF261-A488
interacting with the 40 bp RNA (Fig. 4.2.D). RNA-induced formation of the kinase
domain dimer requires that two PKR monomers bind to the same RNA. The maximum
population of the species containing two bound PKRs, denoted RP2, corresponds to
14% of the total PKR (Table 4.1.) and decreases at higher dsRNA concentration due to
dilution of PKR monomers onto separate strands. The amplitude of anisotropy changes
for the 40 bp dsRNA indicates that a maximum of ~30% of the kinase domains exist as
dimers (Table 1). If the kinase domains quantitatively formed dimers upon sequential
binding of two PKR monomers to an RNA, the ratio of % dimer to % RP2 would equal
one. For the 40 bp dsRNA this value is about two, implying that the maximum dimer
population must be overestimated due to additional sources of depolarization, such as a
small population of RNAs containing three bound PKRs. Regardless of the origin of this
discrepancy, the shape of the anisotropy titration is consistent with the RNA
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concentration dependence of the RP2 species and the amplitude implies that RNAinduced dimerization of the kinase domain occurs efficiently upon sequential binding of
two PKR to the same RNA.

Figure 4.2. Analysis of PKR dimerization induced by activating dsRNAs. (A)
Conjugation of fluorophores with pAzF-substituted PKR. (B) Structure of the PKR kinase
domain parallel dimer (PDB accession 2A1A) rendered in PyMol (Schrödinger). Alexa
Fluor 488 DIBO conjugated at pAzF-261 was modeling onto the structure, with the
ligand indicated in stick representation and the chromophore in green. (C) Anisotropy
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titrations of pAzF-261-A488 with dsRNAs. Samples contained 200 nM pAzF-261-A488.
(D) Species distribution for pAz-F261-A488 binding to the 40 bp dsRNA. The fractional
concencentrations of free protein (P, blue), the the 1:1 complex (RP, red) and the 1:2
complex (RP2, green) are plotted. The fractional concentrations were determined using
the experimentally determined dissociation constants Kd1= 0.324 µM and Kd2 = 0.517
µM (Fig. 4.1). The width of the distributions correponds to the one standard deviation
confidence intervals.

Control experiments confirm that the dsRNA-induced anisotropy changes are due to
FRET within kinase domain dimers. The fluorescence anisotropy of pAz-F261-A488 in
the absence of RNA decreases at high protein concentrations consistent with formation
of a dimer (Fig. 4.1.D). The extent of dimerization is on the order predicted by the Kd
measured by sedimentation equilibrium. Addition of unlabeled PKR to pAzF-261-A488
is expected to reduce the extent of homo-FRET by formation of mixed labeled/unlabeled
heterodimers. Assuming random formation of heterodimers, the anisotropy change
should be linearly in the fraction of labeled PKR. For higher oligomers a nonlinear
dependence is predicted. Figure 4.3.A demonstrates that mixing increasing amounts of
unlabeled PKR with pAzF-261-A488 linearly reduces the anisotropy decrease induced
by binding to a 40 bp dsRNA (R = 0.991 for a linear fit). Alexa Fluor 488 can serve as
an efficient FRET donor to Cy3 (R0 ~ 67 Å). The fluorescence spectrum of a 1:1 mixture
of PKR labeled at pAzF261 with Alexa Fluor 488 and Cy3 overlays with the sum of the
spectra of the two components, indicating the absence of FRET (Fig. 4.3.B). Binding of
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the mixture to the 40 bp dsRNA results in significant donor quenching and enhanced
Cy3 emission due to hetero-FRET. These data support the model where binding of two
PKRs to an activating RNA induces formation of kinase domain dimers.

A

B
Species
Probability F2 2F-F2 (1-F)2
∆r F

R = 0.991

Figure 4.3. Depolarization is due to FRET-induced dimerization. (A) Dependence of
anisotropy on the fraction of labeled PKR. Samples contained 100 nM 40 bp dsRNA
and 200 nM pAz-F261-A488. (B) Analysis of PKR dimerization by hetero-FRET. Donor:
pAz-F261-A488, acceptor: pAz-F261 PKR labeled with DIBO-Cy3. Spectra: 1:1 mixture
(200 nM total) of donor and acceptor (blue), 1:1 mixture (200 nM total) of donor and
acceptor with 100 nM 40 bp dsRNA (red), algebraic sum of 100 nM donor and 100 nM
acceptor spectra (grey).
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4.2.3. PKR dimerization with catalytically inactive constructs
In the PKR dimer interface, R262 forms a salt bridge with D266 (Fig. 3A) and
disruption of this interaction in a R262D PKR mutant blocks kinase activity44. Similarly,
disruption of a hydrogen-bonding interaction between Y323 and D289 in PKR Y323A
reduces activation.

We expected that these mutations block PKR activation by

preventing kinase dimerization and would serve as negative controls for the homoFRET assay. Surprisingly, fluorescence anisotropy titrations indicate that pAzF-261A488 containing either interface mutation undergoes dimerization upon binding to the
40 bp dsRNA (Fig. 4.4.B). The maximal amplitudes of the anisotropy changes are
somewhat smaller than observed for wild-type PKR with a corresponding Dimer/RP2 ~
0.8 (Table 4.1.). PKR autophosphorylation assays confirm that these constructs are
inactive (Fig. S2). Consistent with the anisotropy data, sedimentation equilibrium
analysis of R262D PKR demonstrates reversible dimerization in free solution with Kd of
923 (714, 1267) µM (Figure 4.4.C), or about 2-fold weaker than WT. Similarly, Y323A
PKR also dimerizes with a Kd of 689 (590, 820) µM. Thus, the disruption of interdimer
salt-bridge or hydrogen bonding interactions abolishes PKR activation while only slightly
reducing dimerization affinity.
The reduction in the Dimer/RP2 ratio for R262D indicate less efficient dimerization
or the dimers may have an altered geometry that induces less depolarization. Formation
of an antiparallel dimer modeled on the GCN2 structure would increase the distance
between pAzF-261-A488 fluorophores from 25 to 49 Å resulting in diminished energy
transfer. To test this model, wild-type and R262D PKR were labeled position 301 where
the energy transfer efficiency should be enhanced in a GCN2-type antiparallel, inactive
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dimer relative to the active parallel structure, with interfluorophore distances of 24 and
60 Å, respectively. Titration of either pAzF-301-A488 or pAzF-301-A488/R262D PKR
with 40 bp dsRNA results in a similar low amplitude anisotropy change indicating that
the inactive R262D dimers likely do not adopt a GCN2-type structure.
The 20 bp dsRNA binds a second PKR upon reducing the concentration of NaCl
from 200 to 75 mM13,59. Although this short RNA does not activate PKR at either NaCl
concentration59, it does induce an anisotropy change in 75 mM NaCl (Fig. 4.4.D)
corresponding to a maximum dimer population of about 9%. However, PKR binds very
strongly to the 20 bp RNA at low salt so that the maximum population of RP2 is high
(49%), resulting in Dimer/RP2 of only 0.19 (Table 4.1.). Thus, only a small fraction of
the bound PKRs form dimers upon binding to this short dsRNA.
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Figure 4.4. Dimerization without activation of PKR. (A) Critical intermolecular salt
bridge (R262 – D266) and hydrogen bond (Y323-D289) interactions in the PKR kinase
dimer interface (PDB accession 2A1A) rendered in PyMol (Schrödinger). (B) Anisotropy
titration of pAzF-261-A488 (red), pAzF-261-A488-R262D (blue) and pAzF-261-A488Y323A (green) PKR with 40 bp dsRNA. The anisotropy of the free protein was
subtracted from each data set. (C) Sedimentation equilibrium analysis of R262D PKR.
The points are the data and the solid lines are the best fit. For clarity, only every fourth
point is shown. The inset shows the residuals. Global analysis reveals that R262D
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dimerizes, with a best-fit Kd = 923 (714, 1267) µM

(the values in parentheses

correspond to the one standard deviation confidence intervals) and an RMS deviation of
0.041 fringes. The Kd for WT PKR dimerization under the same conditions is 450 µM.
(D) Anisotropy titration of pAzF-261-A488 PKR with a 20 bp dsRNA in AU200 and AU75
buffer.

4.2.4. Dimerization on barrier containing RNAs
Introducing of helical imperfections into dsRNAs typically reduces PKR binding and
to activation68,69. However, PKR is also activated by certain RNAs that contain bulges,
loops, pseudoknots and single-stranded tails42. PKR can be activated by dimers of
TAR30 and the HDV ribozyme70 that contain short duplex regions separated by a
distorted central region that serves as a barrier. To systematically probe the effect of
structural distortions on PKR dimerization and activation by dsRNA, we introduced
structurally defined, inert, rigid barriers into a model duplex. The dsRBD interacts with
the RNA 2'-OH52 and the barriers consist of 2'-O-methyl dsRNA. The RNAs contain two
15 bp dsRNA regions, the minimal length required to each bind one PKR with high
affinity, separated by variable length 2'-O-methyl dsRNA barriers and are denoted as XMe, where X is the length of 2'-O-methyl dsRNA (Fig. 4.6.A). PKR is not activated by
2'-O-methyl dsRNA71 and does not bind to a 15 bp 2'-O-methyl duplex RNA (Fig. 4.5.).
PKR binding to the barrier-containing RNAs was characterized using sedimentation
velocity analytical ultracentrifugation. As expected, each of the RNAs binds two PKR
monomers (Table 2). The dissociation constants for 5-Me are similar to a 30 bp dsRNA
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(zero-length barrier)13. The dissociation constants for the binding of the first PKR are
not very sensitive to barrier length but Kd2 increases systematically from 5-Me to 15-Me.
PKR activation was strongly affected by the introduction of longer barriers (Fig. 4B).
5-Me activated PKR but 10-Me and 15-Me elicited little to no autophosphorylation.
These results are supported by previous work where introduction of a 11 bp DNA-RNA
chimeric duplex between two 20 bp dsRNAs greatly attenuated PKR activation68.
Binding of pAzF261-A488 to all three barrier-containing dsRNAs results in a significant
anisotropy decrease due to kinase domain dimerization (Fig. 4C). The maximal
anisotropy change is slightly attenuated with increasing barrier length, but even for the
inactive 10-Me and 15-Me constructs it is comparable to that induced by the activating
30 bp dsRNA. All three RNAs have a high Dimer/RP2, indicating efficient kinase domain
dimerization.
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Figure 4.5: Sedimentation velocity analysis of PKR binding to 2'-OH and 2’-O-Me
dsRNAs. Normalized g(s*) distributions of 2.3 µM 15 bp 2'-OH dsRNA (black), 2.3 µM
15 bp 2'-O-Me dsRNA (blue) 2'-OH dsRNA + 2 eq. PKR (red), 2'-O-Me dsRNA + 2 eq.
PKR (green). The peak of the distribution for the 2’-OH dsRNA shifts to a higher
sedimentation coefficient in the presence of PKR due to the formation of a 1:1 complex.
A similar shift is absent for the 2’-O-Me dsRNA, indicating that PKR does not bind. The
shoulder present in the 2'-O-Me dsRNA + PKR sample is due to a contribution from free
PKR (s ~ 3.5 S).
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Figure 4.6 Interaction of PKR with dsRNAs containing 2’-O-methyl barriers. (A)
Schematic of 2’-O-methyl (2'-O-Me) barrier-containing dsRNAs. Chimeric dsRNAs were
designed to contain 5, 10 and 15 bp 2’-O-Me barriers inserted between two 15 bp
dsRNA regions. (B) Activation of WT PKR by 2’-O-Me barrier-containing dsRNAs. The
percent activation is normalized to signal from the 40 bp dsRNA at 100 nM. (C)
Anisotropy titration of pAzF-261-A488 PKR with 2’-O-Me barrier-containing dsRNAs.
For reference, the maximal anisotropy changes associated with PKR binding to regular
30 and 40 bp dsRNAs are indicated by arrows. (D) Fractional concentrations of the 1:2
RNA:PKR complex (RP2) for PKR binding to the 2’-O-Me barrier-containing dsRNAs.
The fractional concentrations were determined using the experimentally determined
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dissociation constants (Table 4.1.). The maximal fraction of RP2 for PKR binding to a 40
bp dsRNA is indicated with an arrow.

Table 4.1. Correlation of PKR dimerization and RNA binding.
Sample

Max. % Dimera

Max. % RP2b

Dimer / RP2c

WT + 40 bp

29.5 ± 0.6

14.3 ± 1.4d

2.06 ± 0.21

R262D + 40 bp

11.4 ± 1.5

14.3 ± 1.4d

0.80 ± 0.13

Y323A + 40 bp

11.1 ± 2.2

14.3 ± 1.4d

0.77 ± 0.17

9.2 ± 0.3

48.8 ± 3.7e

0.19 ± 0.02

WT + 5-Me

20.9 ± 2.1

18.0 ± 1.6f

1.16 ± 0.16

WT + 10-Me

11.6 ± 2.3

10.3 ± 1.8f

1.13 ± 0.30

WT + 15-Me

9.5 ± 1.3

4.7 ± 0.4f

2.02 ± 0.32

24.2 ± 0.5

15.0 ± 1.2g

1.61 ± 0.13

24.6 ± 0.5

21.1 ± 1.8g

1.16 ± 0.10

WT + 20 bp
(75 mM NaCl)

WT +
HO-ss-dsRNA
WT +
ppp-ss-dsRNA
a

Maximum % dimer calculated from the largest anisotropy change and the anisotropy of the
dimer
b

Maximum population of RP2 species based on Kd1 and Kd2 for sequential binding of two PKR
monomers under the conditions indicated.
c

The ratio of the maximal % dimer to the maximal % RP2.

d

Data from Fig. 1.

e

Previously reported13

f

Data from Table 4.2.

g

Mayo C., Wong, C.J. and Cole, J.L. (Submitted).
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Table 4.2. Analysis of PKR binding to barrier-containing dsRNAs.
RNA
5-Me
10-Me
15-Me

Kd1 (nM)

Kd2 (nM)

173

375

(127, 235)
360

(319, 440)
784

(263, 492)
266

(606, 1036)
1,930

(231, 306)

(1709, 2194)

RMSb
0.0067
0.0082
0.0091

Parameters were obtained by global nonlinear least square analysis of sedimentation velocity
measurements. The values in parentheses represent the 95% joint confidence intervals
obtained using the F-statistic.
a

Uncorrected sedimentation coefficient (Svedbergs).

b

Root mean square deviation of the fit in absorbance units.

Discussion
The homo-FRET assay directly probes PKR kinase domain dimerization on RNA
and provides new insights into the factors that distinguish RNA activators and inhibitors.
As previously inferred43, dsRNA activators promote kinase domain dimerization and the
extent of dimerization correlates with activation potency.

These data support a

dimerization model43,45 where activating duplex RNAs function to bring PKR monomers
into close proximity, leading to dimerization of the kinase domains.
PKR binds to dsRNA nonspecifically in multiple configurations20 so that PKR
monomers may be quite far apart along the nucleic acid lattice. Thus, it is noteworthy
that duplex RNA activators ≥30 bp induce efficient dimerization following assembly of
two PKRs onto a single RNA.
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dsRNA by passive diffusion72 and efficient assembly of kinase domain dimers may
occur via this mechanism.
In contrast to longer dsRNAs, kinase domain dimerization is inefficient on short,
nonactivating dsRNA that bind two PKRs in low salt.

The impaired dimerization for

short duplexes is correlated with a difference in RNA binding mode. Affinity cleavage51,
NMR shift perturbation20 and RNA binding analyses20,59 reveal that short dsRNAs that
fail to activate predominantly interact with dsRBD1 whereas longer activators interact
extensively with both dsRBDs. Thus, interaction of dsRBD2 with RNA appears to
regulate kinase domain dimerization despite that fact that these regions are separated
by a long linker. Although this linker is unstructured in the free enzyme34,35,56, it may
become at least partially ordered in the presence of RNA and serve to sterically regulate
kinase domain interactions.
In contrast to perfect duplexes, the correlation between PKR activation and kinase
domain dimerization breaks down in the context of more complex RNAs, indicating that
dimerization is required but not sufficient to activate the kinase. Abrogation of PKR
activation by insertion of 2'-O-Me dsRNA barriers ≥ 10 bp does not appreciably affect
the efficiency of dimerization. A barrier of 10 bp of A-form RNA duplex corresponds to a
distance along the helical axis of only ~ 28 Å. It is reasonable that the barrier does not
disrupt dimerization given that the linker between the dsRBD and the kinase is long and
would be capable of spanning this short distance. However, the larger barriers induce a
change in RNA binding mode that modulates activation, indicating long-range
communication between the dsRBDs and kinase domain. The structural basis for the
dramatic dependence of activation on barrier length is not clear. The effect of barrier
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length on binding affinity for the second PKR (Table 4.1.) implies that weak cooperative
interactions that stabilize binding of the second PKR become attenuated as the length
of the barrier increases.
The relationship between PKR dimerization and activation can be interpreted within
the broader context of the other members of the eIF2α family of protein kinases.
PKR17,73 and PERK63 share a similar back-to-back parallel parallel dimer and
conservation of interface residues suggests that this structure is a common element
among the other eIF2α kinases. We propose that PKR activation requires formation of
a back-to-back parallel interface. Although R262D and Y323A PKR mutations that
disrupt interdimer salt bridge and hydrogen-bonding interactions block PKR
activation44,66 (Fig. 4.4) they do not prevent dimerization at high concentration in the
absence of RNA or upon binding to an activating dsRNA. Although the energy transfer
efficiency of pAzF-261-A488 is reduced by these mutations, implying a rearragement in
the dimer interface, it is not enhanced in pAzF-301-A488/R262D, indicating that the
inactive dimer does not correspond to the model based on the antiparallel GCN2
interface. Some nonactivating RNAs, such as the 20 bp duplex, bind multiple PKRs but
fail to induce kinase domain dimerization. Other nonactivating RNAs, such as the barrier
containing molecules, induce formation of an inactive dimer configuration analgous to
that found in the R262D and Y323A PKR mutants. The allosteric pathway linking the
PKR dimer interface to the kinase active site is likely disrupted in this configuration17,57.
The inactive PKR dimer configuration may provide an additional mechanism for
distinguishing between host and pathogen RNA. High throughput transcriptional
analysis has revealed the presence of hundreds of dsRNAs in human cells74. PKR must
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be able to distinguish host RNAs from pathogen-derived molecules to avoid
inappropriate activation of the innate immunity response. One level of recognition is
achieved based on dsRNA length, where a minimum of ~30 bp of duplex are required
for activation12,13,19,59. Here, regulation of PKR is controlled by dimerization; short
duplexes do not induce dimerization (Fig. 4.4D). In other cases, regulation may be
controlled by the dimer orientation. Our analysis of 2'-O-methyl barrier-containing
duplexes suggests that some secondary structure defects may regulate PKR activation
by induction of inactive dimers and this may serve to prevent aberrant response to host
transcripts.
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Chapter 5: Role of the inter-domain linker

5.1. Introduction
PKR is comprised of two N-terminal dsRNA binding domains (dsRBD) and a Cterminal kinase domain (Fig. 1a). The dsRBDs are separated by a short (~20 amino
acid) linker. NMR analysis indicates that this linker is disordered18. In the human
enzyme, the regulatory and catalytic domains of the protein are separated by a long,
~90 amino acid linker. Residues 169-229 at the N-terminal end of the linker have the
signatures of an intrinsically disordered region (Fig. 1b) with low sequence complexity
and high content of uncharged polar side chains. The C-terminal portion (229-258) is
enriched in basic residues. AFM56, NMR35 and SAXS34 indicate that the linker is flexible
and PKR can adopt a range of closed and open conformations. The PKR kinase domain
crystalizes as a dimer17,73 and biochemical and biophysical analyses support a pivotal
role for dimerization in activation43. PKR dimerizes only weakly (Kd ~ 500 µM); however,
this reaction induces autophosphorylation in the absence of dsRNA31. The isolated
kinase domain is not autoactivated; however, constructs including the adjoining basic
region (228-551) or the entire linker (169-551) are activated in the absence of dsRNA,
implying that the basic domain may contribute to dimerization or regulate activation.
The role of the long interdomain linker in PKR is not well understood. There is
evidence of long-range communication between the dsRBDs and kinase domain.
Kinase domain dimerization is inefficient on short, nonactivating dsRNA that bind two
PKRs in low salt (Husain, B., Hesler S. and Cole, J.L., submitted), suggesting that the
dsRNA binding mode affects kinase dimerization. Insertion of 2'-O-Me inert dsRNA
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barriers in the middle of a 30 bp dsRNA blocks PKR activation but does not impede
dimerization (Husain, B., Hesler S. and Cole, J.L., submitted). Thus, dimerization is
required but not sufficient to activate the kinase and these barrier-containing RNAs
induce a nonproductive kinase dimer configuration.

Although the long linker is

predominantly unstructured in the free enzyme it may become ordered upon binding
RNA. Interestingly, the sequence and length of the N-terminal portion of the linker are
not conserved among mammalian PKR sequences and it is virtually absent in the
Syrian golden hamster (M. auratus) (Fig. 1b). This natural variability suggests that this
region does not play a critical role in the activation mechanism. However, the
contribution of the linker to the structure and function of PKR has not been assessed.
Here, we characterize the functional properties and conformation of a human PKR
construct lacking the variable region that is analogous to the M. auratus enzyme.
Removal of the variable linker results in quantitative but not qualitative changes in
activation, dsRNA binding and flexibility.

5.2. Results
5.2.1. Rationale for studying hamster PKR ortholog
In order to explore the importance of the variable region of the linker, we set out to
characterize hamster (M. auratus) PKR, a naturally occurring PKR variant in which this
region is largely absent. Outside of the linker region missing in the hamster enzyme,
human and hamster PKR are very closely related, with about 60% sequence identity.
Hamster PKR is does not yield soluble protein when it is expressed in E. coli using
conditions optimized for the human enzyme31. Expression at lower temperature in Arctic

	
  

60

Express RIL DE3 cells that supply cold shock chaperones results in increased solubility.
However, the Cpn-10 chaperone binds strongly to hamster PKR and it was not feasible
to produce large amounts of pure enzyme.

Sedimentation velocity measurements

indicate that hamster PKR binds to a 40 bp dsRNA(Fig. 5.1.A). The g(s*) distributions
shift to the right with increasing protein concentration. The magnitude of the shift
indicates that three PKRs bind to the 40 bp RNA. In contrast only two human PKR bind
to this RNA under identical condition13,59. Hamster PKR is activated by 40 bp dsRNA in
a bell-shaped manner analogous to human PKR (Fig 5.1.B). However, the maximum
extent of phosphorylation is ~8 fold higher for the hamster enzyme. The increased
activation potency may be associated with the higher binding stoichiometry.
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Figure 5.1. Functional characterization of Hamster PKR. (a) g(s*) analysis of 40 bp and
Hamster PKR. 0.75 µM 40 bp dsRNA was mixed with 1-6 equivalents of Hamster PKR
and the rate of sedimentation was measured by absorbance AUC. The shift of the
peak of the g(s*) distributions to ~ 9S at 6 equivalents corresponds to a 3:1 PKR:dsRNA
complex. b) Hamster PKR activation by 40 bp dsRNA. Activation was measured with
various concentrations of dsRNA and 100 nM of hamster (red) and human (blue) PKR
32

at 32oC for 15 minutes with 4 µCi of ATP γ- P and 0.4 mM ATP. The samples were
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analyzed by SDS PAGE analysis and autoradiography. Hamster PKR is activated ~8
fold more potently than human PKR.

5.2.2. Functional characterization of PKRΔV
Due to the practical limitations of obtaining pure hamster PKR we examined an
analogous construct derived from human PKR in which the variable region (170-228) is
deleted. This construct, denoted PKRΔV (Fig. 5.2.A), displayed an appreciable
improvement in solubility and stability relative to hamster PKR. The activation and RNA
binding properties of this construct are similar to the hamster enzyme (vide infra). A
construct lacking the linker sequence, PKRΔVB was also created to probe the
importance of the more conserved C-terminal basic region of the linker.
Human PKR is capable of being activated in an RNA-independent fashion at higher
protein concentrations due to weak dimerization31. Similarly, PKRΔV also undergoes
RNA-independent autophosphorylation (Fig 5.3.A). The degree of autophosphorylation
increases with protein concentrations and is significantly enhanced relative to full length
PKR.

At lower protein concentrations where autoactivation is not present, PKR is

activated by dsRNAs of 30 bp or longer. Duplex RNAs also induce PKRΔV to undergo
autophosphorylation with a characteristic bell-shaped activation curve (Fig. 5.3.B). The
longest dsRNA examined (40 bp) activates PKRΔV ~2.5 fold more potently than full
length PKR and the maximum occurs a low dsRNA concentration of 3 nM compared to
about 30 -100 nM for the full-length enzyme. The 30 bp dsRNA is a poor activator of
PKRΔV and no activation is detected for the 20 bp duplex.
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Figure 5.2. PKR domains and linker regions. (a) Domains of PKR and linker deleted
constructs. The interdomain linker contains a variable region (169-229) and a basic
region (229-258) depicted as blue and red solid lines respectively. The middle and
bottom panels show the regions of the linker deleted and the corresponding construct
nomenclature (b) Linker sequence alignment. Sequence alignment of the linker regions
from various PKR homologs were aligned and illustrated using SeaView75. The residues
are coloured based on their charge and hydrophobicity. The alignment shows the
clustering of basic residues in the C terminus of the linker whereas the variable region is
in fact variable in length across species.
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Figure 2. Effect of variable linker region on PKR activation. (a) dsRNA-independent
activation. The extent of PKR (blue) and PKR ΔV (red) autoactivation was measured at
32

0.05 – 2 µM at room temperature following 10 minute incubation with 4 µCi of ATP γ- P.
PKR ΔV auto-activation is ~10 fold greater than for PKR. (b) dsRNA-induced activation.
PKR ΔV activation was monitored at 0.1 µM with varying concentrations of 20 bp
(black), 30 (blue) and 40 bp (red) dsRNA. The percent activation is normalized against
the percentage of PKR activation by 0.03 uM 40 bp dsRNA. The activation shows a bell
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shaped curve and both 20 and 30 bp dsRNAs are poor activators. 40 bp dsRNA
activated PKR ΔV ~2.5 times more potently than it does PKR.

5.2.2. Dimerization of PKRΔV
To test whether the increased activation of PKRΔV is due to enhanced
dimerization, the dimer dissociation constant of PKRΔV was measured by
sedimentation equilibrium (Fig. 5.4.). Data were collected over a protein concentration
range of 0.25 - 2 mg/ml and two rotor speeds and were globally fit to a monomer-dimer
equilibrium model. The best fit Kd = 1.75 (1.43, 2.21) mM, which is about three-fold
weaker than for full length PKR31. Thus, deletion of the variable portion of the linker
actually reduces the dimerization affinity, indicating that the enhanced degree of RNAindependent autophosphorylation of PKRΔV must be due to other effects.
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Figure 5.4. Dimerization of PKR ΔV. The Kd for self-association of PKR ΔV was
measured using sedimentation equilibrium. The data (empty circles) were collected for
0.25 mg/mL, 0.5 mg/mL, 1 mg/mL and 2 mg/mL at 28000 rpm (red) and 18000 rpms
(blue). The data were fit to monomer-dimer equilibrium (solid lines) using
Heteroanalysis and the Kd = 1.75 (1.43, 2.21) mM. The residuals are presented in the
inset as solid circles.
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5.2.2. PKRΔV binding to duplex RNAs
The stoichiometries and affinities for PKRΔV binding to dsRNA were measured
for 20- 40 bp sequences using sedimentation velocity and compared with full length
PKR. The stoichiometries were determined from the magnitude of the shift in the g(s*)
sedimentation coefficient distribution function upon titration of the dsRNA with protein36.
For the 40 bp dsRNA, addition of 6 eq. of PKRΔV induces a large shift from ~ 3.5 S to ~
8 S (Fig. 5.5.A), which is higher than the sedimentation coefficient for the 2:1 complex
formed with full length PKR59. Thus, three PKRΔV bind to the 40 bp dsRNA in AU200
buffer whereas only two full-length PKR monomers bind under comparable conditions.
The data obtained at four protein concentrations were globally fit to this model using
SEDANAL (Fig. 5.5B). A good fit is obtained with a low RMS deviation of 0.0070 OD
and small residuals. The best-fit Kds for the first and second PKR binding events are 75
nM and 56 nM respectively with considerably weaker binding of the third monomer
(Table 1). The value of Kd1 is similar to that observed for the full length enzyme but Kd2
is tighter59, suggesting enhanced cooperativity of binding.
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Table 1. Binding constants for PKRΔV and duplex dsRNAs
RNA

Kd1 (nM)

Kd2 (nM)

Kd3 (nM)

RMSDa

20 bp

235 (189, 286)

-

-

0.0079

30 bp

77 (24, 215)

865 (480, 1700)

-

0.0160

40 bp

75 (43, 121)

56 (27, 99)

2,290 (1,380, 3.870)

0.0070

Parameters obtained by global nonlinear least square analysis of sedimentation velocity
experiments. The values in parentheses represent the 95% joint confidence intervals obtained
using the F-statistic.
a
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(a)

(b)

Figure 5.5. Effect of variable linker region on RNA binding. (a) g(s*) analysis. PKR ΔV
binding to 40 bp dsRNA was measured using absorbance sedimentation velocity
measurements. 0.75 uM 40 bp concentration was fixed and increasing equivalents of
PKR ΔV were analyzed. The g(s*) analysis perfomed using DCDT+ shows that the peak
of the distributions shifts to higher S indicating that protein-RNA complexes are being
formed. (b) Global analysis. The data at all PKR ΔV concentrations were fit globally
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using Sedfit to a 3:1 binding model. The dissociation constants and rmsds are
presented in Table 1.

5.2.2. Conformation analysis of PKRΔV by small angle X ray scattering (SAXS)
Human PKR contains two flexible linker regions and adopts a range of compact and
extended conformations34. The contribution of the variable linker region of PKR to
flexibility was determined by small angle scattering analysis of PKRΔV. Data were
collected over a concentration range from 1 - 5 mg/ml. The parameters derived from
Guinier and GNOM analysis did not vary substantially over this concentration range so
the data at the highest concentration were used for further analysis. A linear Guinier
plot (Fig 5.6.A) indicates the absence of aggregation. The radius of gyration (Rg) of 33.3
Å is substantially smaller than for full length PKR (~ 40 Å)34, indicating that PKRΔV does
not adopt as extended a conformation as the wild type protein. Similar to full length
PKR, the p(r) distribution of interatomic distances peaks at about 30 Å with a tail to
longer distances, suggesting the presence of flexible regions. However, the Dmax for
PKRΔV is smaller (110 Å) relative to full-length PKR (175 Å).

A Kratky plot of the

scattering data (Fig. 5.7.) exhibits a peak at lower q and rises at higher q, which is
characteristic of proteins containing both folded and disordered regions.
Based on the evidence that PKRΔV retains flexibility we have pursued structural
models consisting of three folded domains (dsRBD1, dsRBD2 and kinase) connected by
linkers that can adopt multiple conformations. The EOM76,77 program was used to
generate a large (10,000) pool of structures and select a minimal ensemble from this
pool that best fits the SAXS data. Figures 5.6.C and 5.6.D show distribution of Rg and
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Dmax, respectively, for the initial pool and the ensembles selected by EOM. In both
cases, the selected structures exhibit broad distributions, indicating the contribution of
compact and extended conformations to the ensemble. However, the distributions are
biased towards more compact conformations relative to the random pool, suggesting
the presence of attractive interactions between domains. We have confirmed that
PKRΔV is flexible by fitting the SAXS data using EOM using an ensemble size of one or
alternatively, by rigid body modeling of single structure using BUNCH78. The Χ2 of the
fit increases from 0.996 in the default EOM analysis to 1.303 using an ensemble of one
and 1.56 using BUNCH (data not shown).
The Rg distribution and to a lesser extent, the Dmax distribution, appears bimodal.
This observation implies that PKRΔV may cluster into two families of compact and
extended conformations. Consistent with this picture, the Χ2 of the fit increases only
slightly to 1.056 as the ensemble size is reduced to two. However, simulations indicate
that such bimodal distributions may be artifactual.

A continuous distribution of

structures was simulated by selecting ten conformations from the pool with amplitudes
derived from the pool distribution. Noise equal to the experimental PKRΔV scattering
was added and the resulting simulated data set was fit using EOM with the same pool.
Interestingly, the selected distribution was also bimodal and reducing the ensemble size
to two results in only a marginal increase in Χ2 from 1.023 to 1.040. Thus, the bimodal
shape of the PKRΔV distribution does not necessarily imply the presence of two families
of conformers.

Repeating this process using noise-free data resulting in a selected

distribution that reproduced the underlying pool more faithfully, indicating that the noise
level is an important determinant of the quality of the distributions produced by EOM.
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(a)

(c)

(b)

(d)

Figure 5.6. SAXS analysis of PKRΔV conformation. Data were collected at 4ºC at a
protein concentration of 5 mg/ml.

(a) Scattering data (points) and fit to the p(r)

distribution (solid red line). Inset: Guinier analysis yields Rg = 33.3 ± 0.2 Å. (b) p(r)
distance distribution produced by transforming the data in part (a) using GNOM. Rg (c)
and Dmax (d) distributions produced by fitting the the data in part (a) using EOM. The
distributions of the random pool of 10,000 structures are shown in black dotted lines and
the distributions selected by the genetic algorithm to fit the experimental data are shown
in solid blue. The error bars correspond to the standard deviations of the distributions
produced from three runs of GAJOE.
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5.3. Discussion
It is noteworthy that the length of the interdomain linker in PKR orthologs is highly
variable, leading to the question of how this variable region affects the structure and
function of the enzyme. This region is virtually absent in M. auratus PKR and we initial
sought to compare this construct to human PKR. However, M. auratus is difficult to
obtain in purified form.

We created an analogous deletion construct of the human

enzyme, PKRΔV, which is highly homologous to the M. auratus enzyme and was
chosen as a suitable alternative to probe the role of the variable linker. Control
experiments verify that PKRΔV behaves similarly to M. auratus PKR.
A key observation to emerge from our analyses is that the removal of the variable
region of the linker results in quantitative but not qualitative changes in the catalytic
activity, RNA binding and conformational properties of PKR. The PKRΔV construct
retains enzymatic activity and undergoes both RNA-independent and RNA induced
phosphorylation. The enhanced autoactivation of PKRΔV indicates that the linker in
human PKR negatively regulates the rate of PKR autophosphorylation.

This

enhancement is not simply due to higher affinity dimerization. PKR autophosphorylates
at multiple sites lying within the kinase domain, the basic region and the dsRBD58,79-81.
Potentially the variable length linker separates the domains and limits the rate with
which the kinase domain catalyzes cis phosphorylation of sites within the dsRBD.
Deletion of the linker may allow more rapid phosphorylation of serines and threonines in
the dsRBD due to induced proximity.

Alternatively, the variable region may act as a

steric barrier that limits access to the sites located in the dsRBD.
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As previously observed, the PKRΔV construct exhibits a bell-shape curve for
activation by dsRNA where high concentrations inhibit due to dissociation of PKR
dimers onto separate RNAs12,45. The length dependence of dsRNA activation can be
correlated with binding stoichiometry: like full - length enzyme, 30 bp is the minimal
length capable of binding two PKR and exhibits slight activation. The RNA binding
affinities are similar to those we previously reported for PKR59 with some enhanced
affinity for the second PKR binding the 30 and 40 bp dsRNAs and detection of a third
PKR binding to the 40 bp sequence. Previously, we only detected a third PKR binding
to this sequence upon reducing the NaCl concentration from 200 to 75 mM. The
enhanced affinities for the second and third PKR binding suggests that removal of the
variable linker region enhances cooperativity of PKR assembly.

The enhanced

activation of PKRΔV by the 40 bp dsRNA is likely correlated with the increased binding
affinity for the second and third monomers.
SAXS analysis reveals that PKRΔV retains significant conformational flexibility
despite the removal of the bulk of the interdomain linker. The shapes of the Kratky plot
and p(r) distribution are characteristic of proteins containing disordered regions.
Structural modeling treating the regions lying between dsRBD1 and dsRBD2 and basic
region as flexible linkers reveals that good fits to the scattering data require models that
incorporate an ensemble of conformations. Although we cannot ascribe significance to
the bimodal shapes of the Rg and Dmax distributions, they are clearly biased towards
more compact distributions that than the random pool. Similar bias was observed in our
previous SAXS studies of full length PKR34. NMR chemical shift perturbation18,53
measurements indicate interactions between dsRBD2 and the kinase domain that may
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be responsible for the compaction of the ensemble. This interaction is weak and is
expected to lead to population of both closed and open states55. The persistence of this
conformational bias in PKRΔV implies that the basic linker region remains flexible to
allow the kinase and dsRBD2 to interact; however, further investigation is require to
parse the contributions of the dsRBD1-dsRBM2 linker and the basic region to the
overall flexibility of the PKR.
Our observation that the structural and functional properties of PKR are not strongly
affected by the presence of the variable linker region leads to the questions: why does
this region exist and why do different PKR orthologs contain different length linkers?
PKR is activated by a diverse array of RNAs, some of which contain extensive tertiary
structure42, and we have previously suggested that flexible tethers would permit
dimerization of kinase domains and activation in cases where the dsRBDs of two PKR
monomers are bound at more distal regions of the RNA activators.

34

In this case, the

effects of linker length would become more pronounced for RNAs that contain duplex
binding sites that are far apart. However, PKRΔV is not more susceptible than the fulllength enzyme to the effects of insertion of 2'-O-Me dsRNA barriers in the middle of a
30 bp dsRNA (data not shown). Further investigation using a more diverse range of
PKR ligands may reveal substantial linker dependence. Alternatively, unstructured
regions are often involved in protein-protein interactions82 and PKR is involved in a
plethora of signaling pathways9,10,83 that may be dependent on interactions with the
unstructured linker.
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Chapter 6: The role of the second dsRNA binding domain

6.1. Introduction
PKR contains two N-terminal dsRNA binding domains (p20) separated by a 20-residue
unstructured linker.

Both domains bind preferentially to A form dsRNAs19, and the

interaction is primarily non-sequence specific

18

. Although both domains comprise of a

canonical αβββα motif the dsRBD1 binds dsRNA with a higher affinity than dsRBD2.
However, both domains are required for the high affinity interaction (~30 fold higher) of
p20 to dsRNA, thus indicating that binding is cooperative20,84. Most dsRBD-containing
proteins possess a single copy. It is unclear if dsRBD2 plays a role exclusive of simply
enhancing the overall dsRNA binding affinity. PKR is able to bind short duplexes
between 16-18 bps. However, a minimum of 30 bp is required to induce PKR
autophosphorylation12,13. NMR HSQC analyses of p20 show significant chemical shift
perturbations of residues spanning both dsRBD1 and 2 upon 40 bp binding20. Yet,
binding to 20 bp dsRNA produces perturbations within dsRBD1 and in the N terminal
regions of dsRBD2. Affinity cleavage experiments performed to map the binding site for
p20 and various dsRNA ligands show that both dsRBDs interact with activating
dsRNAs, whereas only a single dsRBD binds to non-activating ones51. These results
suggest that PKR activation is correlated with the binding of both dsRBDs to the
dsRNA, whereas non-activating dsRNAs bind dsRBD1 and are unable to bind the entire
dsRBD2. In order to elucidate the importance of the dsRBD2 we created mutations
sequentially in various regions within the domain that are predicted to make dsRNA
contacts. The objective of this study was to create a construct that was able to bind
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dsRNA solely via the dsRBD1 regardless of the dsRNA ligand and test the importance
of dsRBD2 binding on activation. dsRNA binding and activation was measured with the
dsRBD2 mutants and 1H-15N HSQC measurements were performed to confirm that the
dsRBD2 interaction was abolished.
6.2. Results
6.2.1. Rationale for the selection of dsRBD2 mutants
There is currently no structure available of the complex of PKR’s dsRBD with dsRNA. A
structure of a canonical Xlrbpa-2, bound to dsRNA confirmed that binding is nonsequence specific and that majority of the interactions occur between charged polar
amino acids and 2’OH and phosphodiester oxygens on the dsRNA11. Xlrbpa-2 footprint
on the dsRNA spans two minor grooves and the intervening major grove. The binding
interface comprised of regions 1, 2 and 3 on Xlrbpa-2. The corresponding residues in
dsRBD1 and dsRBD2 are shown in Fig. 6.1.A. Alanine substitutions in dsRBD2 were
made sequentially to estimate the relative importance of each region. The locations
were selected based on sequences conservation with Xlrbpa-2 and their solvent
accessibility. K150A mutation was previously found to be critical for dsRNA binding51. A
construct containing substitutions H126A, K150A and Q151A (KQH) was created to
eliminate contacts predicted to occur within regions 2 and 3. A quad mutant with an
additional N106A (KQHN) was made to eliminate contacts in all three regions. We
chose to abolish dsRBD2 binding by making point mutations rather than deletion the
domain as a whole to more closely match a physiological construct and to avoid any
perturbation of PKR’s overall structure or dynamics.
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Figure 6.1. Model for intermolecular interactions between dsRBD2 and dsRNA. A)
Sequence alignment of PKR dsRBD1, PKR dsRBD2 and Xlrbpa-2. Residues in regions
1 (red), 2 (blue) and 3 (green) are highlighted in bold. B) The structure of a complex of
Xlrbpa-2 with dsRNA (PDB accession 1DI2) was used to develop a model for the
interaction of PKR dsRBD2 with dsRNA (green). PKR dsRBD2 from the NMR structure
of dsRBD1-dsRBD2 (PDB accession 1QU6) was aligned with Xlrbpa-2 and rendered in
PyMol (Schrödinger). Xlrbpa-2 (ribbon, cyan), dsRNA (stick, beige), PKR dsRBD2
(ribbon, green). Key conserved residues that form the dsRNA-binding interface
spanning regions 1, 2 and 3 are indicated.
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6.2.2. Characterization of dsRBD2 mutants
The effects of the dsRBD2 mutations on dsRNA binding were assessed by
characterizing their interaction with 40 bp dsRNA by sedimentation velocity analytical
ultracentrifugation. Initally, the PKR mutants were characterized in the absence of RNA
to determine homogeneity and conformation. The sedimentation coefficients of the PKR
mutants were determined by fitting the sedimentation velocity data to a single species
model. The sedimentation coefficients of the mutants are similar to that of WT PKR
(Table XX: Show s20,w) indicating that the mutations do not perturb the native
conformation of the free enzyme. All constructs bound 40 bp with a 2:1 stoichiometry,
similar to WT PKR. RNA binding titrations were performed with increasing
concentrations of each dsRBD2 mutant and fixed concentration of 40 bp dsRNA (0.5
µM). The Kd1 for binding increases ~ 4 fold for the K150A mutant compared to WT PKR
(Table 6.1). Mutagenesis of residues K150, Q151A and H126A, spanning regions 1 and
2 of the binding interface results in further weakening of binding (~10 fold for Kd1).
Interestingly, Kd2 remains unaffected. However, addition of the N106A mutation causes
a ~ 4 fold decrease in Kd2 as well. Activation of the three constructs was measured with
40 bp dsRNA (Figure 6.2). The reactions contained fixed amounts of protein (0.2 µM)
and 0-3 µM of 40 bp dsRNA and they were initiated by the addition of 4 µCi of [γ-32P]
ATP and 0.4 mM ATP. The autoradiograms show that the KQN mutant does not exhibit
an appreciable difference in dsRNA-induced autophosphorylation compared with WT
PKR (Figure 6.2.A). However, the KQHN is virtually incapable of activation above
background levels (Figure 6.2.B). These results indicate that either the combination of
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N106A with the other mutations resulted in the complete loss of dsRBD2-dsRNA
binding or that N106A alone is capable
Table 6.1. Binding constants for 40 bp and dsRBD2 mutants
PKR construct

Kd1 (nM)

Kd2 (nM)

RMSDa

K150A

162 (119, 221)

429 (350, 509)

0.0070

484 (292, 818)

323 (241, 425)

0.0122

341 (217, 529)

1694 (1273, 2290)

0.0106

K150A,Q151A,
H126A
K150A,Q151A,
H126A,N106A
Parameters obtained by global nonlinear least square analysis of sedimentation velocity
experiments. The values in parentheses represent the 95% joint confidence intervals obtained
using the F-statistic.
a

Root mean square deviation in absorbance units

Figure 6.2: Simulation of fraction RNA-PKR2 for wild type and KQHN PKR. The
simulation was performed using IGOR Pro (Wavemetrics Inc) using the dissociation
constants for WT and KQHN PKR and 40 bp dsRNA.
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Figure 6.3: Activation of dsRBD2 mutants by 40 bp dsRNA. A) Activation of KQH
PKR B) Activation of KQHN PKR. Activation assays were performed with 0.2 µM PKR
and 0 – 3.0 µM 40 bp dsRNA in AU200 buffer. Reactions were initiated by adding 4 µCi
of [γ-32P] ATP and 0.4 mM ATP for 40 minutes at 32oC. Samples were analyzed using
SDS PAGE and autoradiography.

6.2.3. 1H-15N HSQC analysis of dsRBD
The KQHN construct was designed to abolish dsRBD2 binding to dsRNA. The decrease
in binding affinity indicates that the interaction of dsRBD2 with RNA is affected, but does
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not prove that binding is completely eliminated. NMR chemical shift perturbation
experiments were used to directly probe PKR-RNA interactions at the single residue
level. Experiments were conducted with p20 with and without KQHN subtitutions (Figure
6.4) Spectra were collected with 0.1 mM p20 and p20-KQHN under conditions used
previously. The spectra were overlaid and several of the crosspeaks, mainly those in the
dsRBD2 had shifted in the KQHN p20 (Figure 6.5).

Figure 6.4: Schematic of dsRBD construct for NMR HSQC analysis. dsRBD2dsRNA interaction or lack thereof was determined using 1H-15N HSQC analysis with and
without 40 bp dsRNA.
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Figure 6.5: 1H-15N HSQC analysis of p20 and KQHN p20. The spectra were acquired
on Varian Inova 800 MHz instrument with 0.1 mM p20 or quad mutation (K150A,
Q151A, H126A, N106A) in 20 mM sodium phosphate, pH 6.6, 100 mM sodium chloride,
0.1 mM TCEP at 25oC. Existing assignments of p2085 were mapped onto the spectra
using CcpNMR analysis 86.
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dsRBD1

dsRBD2

	
  

	
  

Figure 6.6: Analysis of normalized peak intensities upon dsRNA titration. Normalized
intensity for p20 (black) or KQHN p20 (red) with A) 3.5 µM 40 bp dsRNA and B) 6.95
µM 40 bp dsRNA.
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The spectra for p20-KQHN is well dispersed, indicating that the construct is well folded
and that although the mutagenesis caused small local changes in the environment of
dsRBD2 the overall conformation remained similar to WT p20. The existing 1H-15N
HSQC spectral assignments for p20 were mapped on the spectra

18

(Figure 6.5). The

spectra under our conditions were slightly shifted overall compared to the original
assignments, likely due to subtle changes in experimental conditions. 0.35 and 0.695
equivalents of 40 bp dsRNA was titrated into p20 and KQHN-p20 samples and the
spectra were collected. No clear peak shifts were observed upon dsRNA addition,
however, the overall peak intensities decreased with increasing dsRNA concentrations.
The normalized intensities for the assigned residues were plotted and compared
between WT p20 and KQHN p20 at each dsRNA concentration (Figure 6.6). An overall
decrease of ~40% was observed with residues in dsRDB1 for WT p20 compared to ~
80% in KQHN-p20 (Figure 6.6.A With 0.35 equivalents of 40 bp dsRNA the residues in
dsRBD2 are less perturbed than dsRBD1 for both p20 and KQHN p20. However, the
relative differences in perturbation in the two domains are far greater for KQHN-p20.
These results may suggest that dsRBD2 in KQHN p20 may not interact directly with the
dsRNA.

At 0.695 equivalents of 40 bp dsRNA the intensities decreased further in

dsRBD1 and dsRBD2 for both constructs. The overall reduction in the intensities may
be a consequence of the formation of large heterogeneous RNA-PKR complexes in
solution due to the complex equilibria for p20-RNA interaction20. Further HSQC
analyses are required to conclusively ascertain whether dsRBD2 binds dsRNA in the
KQHN construct. The overall decrease in the intensity of the cross peaks may be
reduced by mixing 40 bp and p20 in stoichiometric proportions. This should produce a
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homogeneous mixture of RNA-p201 species over higher order complexes such RNAp202, RNA-p203 and RNA-p204, which are likely to contribute to the broadening of the
cross peaks.
6.3. Discussion
PKR contains two tandem dsRBDs which bind variable length dsRNAs. The footprint of
a single dsRBD on dsRNA is ~16 bps18. Only dsRNA with lengths 30 bp or higher can
activate PKR. dsRBD1 binds dsRNA tighter than dsRBD2, but both motifs are required
for high affinity interaction with dsRNA. NMR20, AUC20, and affinity cleavage51
experiments provide evidence to suggest that dsRBD2 is required to bind to dsRNA to
induce activation. To test the model we sequentially mutated key residues predicted to
participate in the dsRBD2-dsRNA binding interface. Functional characterization of the
mutants were performed and it was observed that KQHN did not activate with 40 bp
dsRNA. The KQH mutant, however, is still active and the Kd2 remains unaffected
compared to WT PKR. The binding affinities of KQHN compared to WT PKR were
weaker for Kd1 by ~ 10 fold and ~4 fold for Kd2. The weakening of Kd2 with the KQHN
and not KQH may suggest that the dsRBD2 of the second PKR may bind 40 bp via
region 1 alone, whereas that of the first PKR binds via all three regions. The abolishing
of activation with the KQHN mutant may be due to a cumulative effect of mutating all
three regions of the dsRBD2. Alternately, the effect could be due to N106A alone,
suggesting that it is a key regulatory residue in the dsRNA binding and activation.
Further characterization of a single N106A mutant is required to ascertain the role of
N106 in PKR activation. Viral and cellular RNAs with complex secondary structures are
able to bind and activate PKR. dsRNAs containing 2’-O-methyl barriers between 15 bp
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duplex stretches are able to bind two PKRs but do not induce activation(Bushra Husain,
Stephen Hesler, James Cole; 2015). Notably, differences in the dsRNA structure and
composition can translate to inability for PKR activation suggesting a mechanism for
inter-domain communication. This may occur either through the inter-domain linker or
perhaps through transient interactions between dsRBD2 and the kinase domain. In such
as scenario, the role of the dsRBD2 may be more significant than to simply serve as a
redundant domain required for high affinity binding of the dsRBD to dsRNA through
cooperative assembly.
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Chapter 6: Conclusions and future direction

During viral infection PKR recognizes RNAs that possess an array of complex
secondary structural elements such as bulges, loops and mismatches68. Despite PKRs
preference for duplex stretches of dsRNA it is still able to bind and become activated by
structured RNAs. Viruses synthesize decoy RNAs such as VAI from Adenovirus and
EBER1 and EBER2 from Epstein Barr virus, which bind and sequester PKRs in solution
minimizing the PKR-mediated response87,88. An elusive aspect of this inhibition process
is the ability for PKR to distinguish non-activating and activating RNAs, since many of
them possess similar structural features.
The assembly of more than one PKR on a dsRNA is critical since activation is
linked closely with dimerization. A FRET–based dimerization assay was presented
(Chapter 4) which allowed us to directly probe PKR dimerization upon dsRNA binding.
The results showed that dsRNAs containing fairly short stretches of 2’O-methyl RNA
between 15 bp duplex regions are able to bind two PKRs, but don’t activate.
Interestingly, these RNAs induced dimerization. Dimer interface mutants R262D and
Y323A were previously thought to be catalytically inactive due to their inability to
dimerize17. However, we observed that both mutants dimerize upon dsRNA binding as
well as in the absence of dsRNA. Our results reveal the presence of a novel inactive
dimer species that may serve to regulate its activation when bound to a specific dsRNA
ligand. Interestingly, the dsRNA structure can affect the nature of the dimer
configuration. A specific back-to-back dimer is critical for PKR activation.
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PKR belongs to a family of eIF2α kinases. PERK60 (PKR-like endoplasmic
reticulum kinase) and PKR exist as unphosphorylated monomers in solution. In the
presence of an activating dsRNA they form the back-to-back dimer and become active.
GCN2

62

(general control non-derepressible 2) and HRI61 (heme-regulated inhibitor

kinase) exist as constitutive inactive dimers in solution. However, a rearrangement of
their dimer interface is required for activation. Since the eIF2α kinases participate in a
myriad of pathways that eventually lead to cell death, activation must be tightly
regulated within the cell. Inactive dimer configurations may exist to lock the kinases and
prevent any aberrant or background activation. High throughput transcriptional analysis
show that human cells can produce hundred of dsRNA74. PKR-dsRNA binding is nonsequence specific and under low salt conditions even short RNAs can bind more than
one PKR13,59. Inactive PKR dimers may form to prevent inappropriate activation upon
binding to host dsRNA ligands. The nature of the inactive dimer interface, however,
remains elusive. Dimerization assays performed using a FRET pair at position 301
instead of 261 demonstrate that PKR does not form a GCN2-like antiparallel inactive
dimer interface. Future experiments to probe the inactive dimer interface can involve
the characterization of PKR constructs with FRET pairs at several different locations on
the kinase dimer. Alternately, high resolution structural analyses of catalytically inactive
mutants R262D or Y323A mutants will likely answer the questions pertaining to the
specific inactive dimer interface.
Although PKR activation has been studied extensively, the precise mechanism of
autophosphorylation is elusive since the active dimer is oriented such that the active site
clefts are facing away from each other. Cis-phosphorylation of T446 has been
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suggested as a likely first step in activation followed by the trans-autophosphorylation at
multiple serine and threonine sites making the enzyme fully active65. To test the various
binding interfaces of the kinase domains at different stages in activation a number of
FRET pair containing constructs can be designed and assayed. For example, FRET
pairs can be incorporated that show enhanced energy transfer when a front-to-back or
front-to-front interface is formed.
The isolation and high-resolution characterization of dimeric PKR species is
challenging since they are interact weakly and reversibly in solution. The creation of
constructs with strategically placed cysteine pairs can allow us to trap dimers via
disulfide bonding, and purify them for biophysical or structural characterization.
PKR contains a ~90 residues interdomain linker. The N-terminal regions (169228) is variable in length across different orthologs and is absent in hamster PKR. The
C-terminal end is shorter and is enriched in positively charged residues. AFM56, NMR35
and SAXS34 analysis show that PKR exists in ensemble of conformations likely due to
the disorder in the linker. The linker also presents a challenge for the crystallization of
the full-length enzyme.

To define the role of the linker we created linker-deleted

constructs PKRΔV and PKRΔVB and functionally characterized them (Chapter 5).
PKRΔV autophosphoryalates in the absence of dsRNA much more potently than WT
PKR. In addition, it binds to 40 bp dsRNA with a higher stoichiometry than WT PKR.
Overall, the construct is potently active since increased dsRNA binding stoichiometries
are directly correlation with higher levels of activation. These results suggest that the
long unstructured linker serves to negatively regulate PKR activation by curbing
background autophosphorylation and limiting PKR assembly on dsRNAs. L18 protein of
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the 60 S ribosomal unit, which is overexpressed in patients with colorectal cancer
sequesters PKR via the dsRNA binding domain and prevents it from activating89. This
indicates that the cells likely employ several pathways to negatively regulate PKR
activity.
The linker-deleted constructs of PKR have thus far only been characterized with
duplex RNAs. They may play a role in recognizing secondary structural elements of
RNAs that exist and bind PKR in vivo. Further experiments can be conducted to
characterize the role of the linker in recognition of structured RNAs or ss-dsRNAs. One
of the most well studied consequences of PKR activation is eIF2α phosphorylation.
However, PKR participates in several pathways involving cell differentiation, cell growth,
heat shock stress, UV stress, bacterial infection, etc. It is possible that the linker may
play a larger role in signaling and other downstream processes.
Most dsRBD-containing proteins possess a single copy. The footprint of a dsRBD
on a dsRNA is 16 bps. Yet, PKR, which has two such dsRBDs is able to bind 20 bp
dsRNAs in a 2:1 stoichiometry. Interestingly, these dsRNAs do not induce activation.
NMR20 and AUC analyses demonstrate that the inability to activate is due to the
impaired dsRBD2 binding. We tested this model by mutating residues within the
dsRBD2 that are predicted to bind dsRNA based on sequence and structural homology
with Xlrbpa2 (Chapter 6). The quad mutant K150A, Q151A, H126A, N106A is able to
bind PKR in a 2:1 stoichiometry but does not activate. These results suggest that
specific contacts made between the dsRBD2 and dsRNA are essential for dsRNAinduced PKR activation. Interestingly, the triple mutant K150A, Q151A, H126A is able to
activate suggesting that N106A may play a key role in dsRNA-induced activation.
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Ongoing experiments in the lab involve the functional characterization of N106A
single mutant. More detailed chemical shift measurements also need to be performed
with p20 WT and quad mutant constructs to ascertain if the mutations are blocking
dsRBD2 binding.
In summation, we have developed a reproducible and reliable FRET-based assay
to measure dimerization of PKR upon dsRNA binding. This assay with can be used with
virtually any ligand as long as the anisotropy differences elicited by depolarization are
large enough and measurable. Our assays reveal a novel inactive dimer species, which
may exist as a mechanism for PKR to distinguish host and viral dsRNAs. We have
determined that the unstructured linker serves to negatively regulate PKR activation in
the absence of an appropriate stimulus. The role of the second dsRBD has also been
explored. Mutation of residues predicted to lie within the dsRBD-dsRNA interface block
PKR activation, but reduce dsRNA binding affinity by ~4 fold compared to WT PKR.
These results suggest that a dsRBD2 mediated dsRNA binding may be key for
activation, and that PKR may distinguish activating and non-activating dsRNAs based
on the relative affinity of the dsRBD2.
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